770 genotypes with 978 annotations displayed
of selected term and subterms
|
Searched Term: abnormal endocrine gland physiology
|
4931414P19Rikem1Lych/4931414P19Rikem1Lych
(involves: C57BL/6)
|
decreased activity of thyroid gland
|
J:275266
|
Aanatrs216509331-A/Aanatrs216509331-A
(C57BL/6J)
|
abnormal pineal gland melatonin secretion
|
J:27126
|
abnormal pineal gland physiology
|
J:27126
|
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrj * CBA/JNCrj)
|
decreased activity of thyroid gland
|
J:99152
|
Abca5tm1Akya/Abca5tm1Akya
(involves: C57BL/6NCrlj * CBA/JNCrlj * ICR)
|
decreased activity of thyroid gland
|
J:99152
|
Abcc8tm1.1Fmas/Abcc8tm1.1Fmas
(B6.129S2(Cg)-Abcc8tm1.1Fmas)
|
decreased insulin secretion
|
J:208932
|
increased insulin secretion
|
J:208932
|
Abcc8tm1.1Mgn/Abcc8tm1.1Mgn
(involves: 129X1/SvJ * C57BL/6)
|
decreased insulin secretion
|
J:79352
|
Abcc8tm1Jbry/Abcc8tm1Jbry
(involves: 129X1/SvJ)
|
abnormal insulin secretion
|
J:179577
|
decreased insulin secretion
|
J:179577
|
Abcc8tm1Jbry/Abcc8tm1Jbry Sstr5tm1Fcb/Sstr5tm1Fcb
(involves: 129X1/SvJ)
|
abnormal insulin secretion
|
J:179577
|
decreased insulin secretion
|
J:179577
|
Abhd6tm1a(EUCOMM)Hmgu/Abhd6+
(C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu)
|
increased insulin secretion
|
J:215257
|
Abhd6tm1a(EUCOMM)Hmgu/Abhd6tm1a(EUCOMM)Hmgu
(C57BL/6N-Abhd6tm1a(EUCOMM)Hmgu)
|
abnormal pancreatic beta cell physiology
|
J:215257
|
decreased insulin secretion
|
J:234876
|
increased insulin secretion
|
J:215257,
J:234876
|
Abhd6tm1c(EUCOMM)Hmgu/Abhd6tm1c(EUCOMM)Hmgu Tg(Ins1-cre/ERT)1Lphi/0
(involves: C57BL/6N * CD-1)
|
increased insulin secretion
|
J:215257
|
Acetm1Unc/Ace+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased insulin secretion
|
J:128859
|
Acetm3Unc/Ace+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased insulin secretion
|
J:128859
|
Adgra1tm1.1Zgwg/Adgra1tm1.1Zgwg
(Not Specified)
|
increased activity of thyroid gland
|
J:329982
|
Adipoqtm1Ish/Adipoqtm1Ish
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased insulin secretion
|
J:199264
|
Adra1btm1Cta/Adra1btm1Cta
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal pancreatic beta cell physiology
|
J:87718
|
Adrb2tm1Kry/Adrb2tm1Kry Tg(Col1a1-cre)1Kry/0
(involves: FVB)
|
abnormal insulin secretion
|
J:145998
|
Afmidtm1b(EUCOMM)Wtsi/Afmidtm1b(EUCOMM)Wtsi
(C57BL/6N-Afmidtm1b(EUCOMM)Wtsi/H)
|
decreased insulin secretion
|
J:226537
|
Ago2tm1.1Tara/Ago2tm1.1Tara Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
decreased pancreatic beta cell proliferation
|
J:210552
|
Airetm1.1Doi/Airetm1.1Doi
(NOD.129S2(B6)-Airetm1.1Doi/Doi)
|
thyroid gland inflammation
|
J:107432
|
Airetm1.1Doi/Airetm1.1Doi
(NOD.129S2-Airetm1.1Doi)
|
thyroid gland inflammation
|
J:135154
|
Airetm1Mand/Aire+
(NOD.129P2-Airetm1Mand)
|
thyroid gland inflammation
|
J:135154
|
Airetm1Mand/Airetm1.1Doi
(NOD.129-Airetm1Mand/Airetm1.1Doi)
|
thyroid gland inflammation
|
J:135154
|
Airetm2Mmat/Airetm2Mmat
(involves: C57BL/6 * CBA)
|
abnormal thymus physiology
|
J:141379
|
Akap5tm1.1Jsco/Akap5tm1.1Jsco
(involves: 129S * C57BL/6)
|
decreased insulin secretion
|
J:190017
|
Akap5tm1Jsco/Akap5tm1Jsco Tg(Ins2-cre)25Mgn/0
(involves: 129S * C57BL/6 * DBA)
|
increased insulin secretion
|
J:190017
|
Akap5tm1Mdaq/Akap5tm1Mdaq
(involves: 129 * C57BL/6 * C57BL/6J)
|
decreased insulin secretion
|
J:190017
|
Akt1tm1Nhy/Akt1+ Akt2tm1Rsg/Akt2tm1Rsg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1LacJ)
|
decreased insulin secretion
|
J:149156
|
Albtm1(cre/ERT2)Mtz/Albtm1(cre/ERT2)Mtz Slc2a2tm2Thor/Slc2a2tm2Thor
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased insulin secretion
|
J:197607
|
Aldh1b1tm1.1(KOMP)Vlcg/Aldh1b1tm1.1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac * CBA)
|
decreased insulin secretion
|
J:232360
|
increased glucagon secretion
|
J:232360
|
increased insulin secretion
|
J:232360
|
increased pancreatic beta cell apoptosis
|
J:232360
|
increased pancreatic beta cell proliferation
|
J:232360
|
Alox15tm1.1Nadl/Alox15tm1.1Nadl Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA)
|
abnormal pancreatic beta cell physiology
|
J:224344
|
increased insulin secretion
|
J:224344
|
Alx3tm1Hubr/Alx3tm1Hubr
(involves: 129P2/OlaHsd)
|
abnormal pancreatic beta cell physiology
|
J:166436
|
decreased insulin secretion
|
J:166436
|
increased pancreatic beta cell apoptosis
|
J:166436
|
Ank2tm3.1Bnt/Ank2tm3.1Bnt
(B6.129(C)-Ank2tm3.1Bnt/J)
|
decreased insulin secretion
|
J:222913
|
Anxa1tm1Rjf/Anxa1tm1Rjf
(involves: 129 * C57BL)
|
abnormal adrenal gland secretion
|
J:129587
|
Anxa7tm1Pll/Anxa7+
(Not Specified)
|
abnormal pancreatic beta cell physiology
|
J:58572
|
decreased insulin secretion
|
J:58572
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc)
|
hypersecretion of corticosterone
|
J:60585
|
hypopituitarism
|
J:60585
|
Aqp7tm1Chan/Aqp7tm1Chan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased insulin secretion
|
J:125011
|
Arfgef3tm1Hong/Arfgef3tm1Hong
(129.129P2(B6)-Arfgef3tm1Hong)
|
increased insulin secretion
|
J:216529
|
Arnt2tm1Yfk/Arnt2tm1Yfk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pituitary secretion
|
J:74118
|
Arti1C57BL/6J/Arti1C57BL/6J Arti2C57BL/6J/Arti2C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal thymus involution
|
J:85261
|
Arti1DBA/2J/Arti1DBA/2J Arti2DBA/2J/Arti2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal thymus involution
|
J:85261
|
AsmtC57BL/6JJcl/AsmtC57BL/6JJcl
(C57BL/6JJcl)
|
abnormal pineal gland melatonin secretion
|
J:159317
|
Atcayji/Atcayji
(Not Specified)
|
abnormal thyroid gland physiology
|
J:14903
|
Atf4tm1Kry/Atf4tm1Kry Tg(Col1a1-cre)1Kry/0
(involves: C57BL/6J * FVB)
|
increased insulin secretion
|
J:152695
|
Atf4tm1Tow/Atf4+ Ptprvtm1Asmi/Ptprv+
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss))
|
increased pancreatic beta cell proliferation
|
J:152695
|
Atf4tm1Tow/Atf4tm1Tow
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J * NIH Black Swiss) or (involves: 129P2/OlaHsd * C57BL/6J * NIH Black Swiss))
|
increased insulin secretion
|
J:152695
|
increased pancreatic beta cell proliferation
|
J:152695
|
Atg5tm1Nmz/Atg5tm1Nmz Tg(CAG-EGFP/Map1lc3b)53Nmz/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal thymus physiology
|
J:140583
|
Atmtm1Pmc/Atmtm1Pmc Trp73tm2Mak/Trp73tm2Mak
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased thymocyte apoptosis
|
J:157905
|
Atrtm1Bal/Atrtm2Bal Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
abnormal thymus involution
|
J:123200
|
Atxn2tm1.1Aub/Atxn2tm1.1Aub
(involves: 129P2/OlaHsd * C57BL/6)
|
increased insulin secretion
|
J:135320
|
Badtm1Meg/Badtm1Meg
(involves: 129S4/SvJae)
|
decreased insulin secretion
|
J:133563
|
increased pancreatic beta cell apoptosis
|
J:133563
|
Badtm1Sjk/Badtm1Sjk
(involves: 129X1/SvJ)
|
abnormal pancreatic beta cell physiology
|
J:133563
|
decreased insulin secretion
|
J:133563
|
Badtm2Meg/Badtm2Meg
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
decreased insulin secretion
|
J:133563
|
Bak1tm1Thsn/Bak1tm1Thsn Baxtm2Sjk/Baxtm2Sjk Tg(Lck-cre)1Cwi/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased thymocyte apoptosis
|
J:220951
|
Bcap31tm1.1Bwang/Bcap31tm1.1Bwang Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
increased thymocyte apoptosis
|
J:274469
|
Bcl2tm1Sjk/Bcl2tm1Sjk
(involves: 129S2/SvPas * C57BL/6)
|
abnormal thymus involution
|
J:15224
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(involves: 129S1/Sv)
|
decreased thymocyte apoptosis
|
J:266833
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast Mlf1tm1Swm/Mlf1tm1Swm
(involves: 129S1/Sv * C57BL/6)
|
decreased thymocyte apoptosis
|
J:266833
|
Bcl2l11tm3Rjd/Bcl2l11tm3Rjd
(B6.129S6-Bcl2l11tm3Rjd)
|
decreased thymocyte apoptosis
|
J:137061
|
Bcl11btm1Avram/Bcl11btm1Avram Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal thymocyte activation
|
J:128515
|
Bcl11btm1Jpk/Bcl11btm1Jpk
(involves: BALB/c * C57BL/6 * CBA)
|
increased thymocyte apoptosis
|
J:83651
|
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd)
|
decreased insulin secretion
|
J:126780
|
decreased pancreatic beta cell proliferation
|
J:126780
|
Bglap/Bglap2tm1Kry/Bglap/Bglap2tm1Kry
(involves: 129S7/SvEvBrd)
|
decreased insulin secretion
|
J:126780
|
decreased pancreatic beta cell proliferation
|
J:126780
|
Birc6tm1Nai/Birc6tm1Nai
(involves: 129S4/SvJae * C57BL/6J)
|
increased thymocyte apoptosis
|
J:96768
|
Bmal1tm1.2Shbi/Bmal1tm1.2Shbi
(involves: C57BL/6J)
|
decreased insulin secretion
|
J:177865
|
Bmal1tm1Bra/Bmal1tm1Bra
(involves: 129/Sv * C57BL/6)
|
decreased insulin secretion
|
J:162641
|
Bmal1tm2Bra/Bmal1tm2Bra Tg(Pdx1-cre)89.1Dam/0
(involves: 129 * C57BL/6 * C57BL/6J * CBA * ICR)
|
abnormal pancreatic beta cell physiology
|
J:162641
|
decreased insulin secretion
|
J:162641
|
Bmi1tm1Brn/Bmi1tm1Brn
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB))
|
abnormal thymus involution
|
J:17712
|
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased thymocyte apoptosis
|
J:170095
|
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1)
|
increased thymocyte apoptosis
|
J:170095
|
Braftm1Bbd/Braf+
(B6.129-Braftm1Bbd)
|
increased thymocyte apoptosis
|
J:170095
|
Braftm1Cpri/Braftm1Cpri Tg(TPO-cre)1Shk/0
(involves: 129P2/OlaHsd * FVB/NCr)
|
decreased activity of thyroid gland
|
J:168249
|
Braftm1Mmcm/Braf+ Tg(Tg-cre/ERT2)#Mmcm/0
(involves: 129P2/OlaHsd)
|
decreased activity of thyroid gland
|
J:172205
|
C1qtnf5tm1(KOMP)Vlcg/C1qtnf5tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
increased insulin secretion
|
J:237401
|
C1qtnf9tm1(KOMP)Vlcg/C1qtnf9tm1(KOMP)Vlcg
(C57BL/6-C1qtnf9tm1(KOMP)Vlcg)
|
increased insulin secretion
|
J:212299
|
C2cd5Gt(IST12020E4)Tigm/C2cd5Gt(IST12020E4)Tigm
(C57BL/6N-C2cd5Gt(IST12020E4)Tigm)
|
abnormal adrenal gland secretion
|
J:284780
|
Cacna1ctm3Hfm/Cacna1ctm3Hfm Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
abnormal pancreatic beta cell physiology
|
J:84919
|
decreased insulin secretion
|
J:84919
|
Cacna1dtm1Hssh/Cacna1dtm1Hssh
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal pancreatic beta cell physiology
|
J:72316
|
decreased insulin secretion
|
J:72316
|
decreased pancreatic beta cell proliferation
|
J:72316
|
Cacna1etm1.1Tsch/Cacna1etm1.1Tsch
(involves: C57BL/6)
|
abnormal glucagon secretion
|
J:95377
|
abnormal pancreatic beta cell physiology
|
J:95377
|
decreased insulin secretion
|
J:95377
|
Cacna1etm1.1Tsch/Cacna1etm1.1Tsch
(involves: BALB/cJ * C57BL/6)
|
decreased glucagon secretion
|
J:101873
|
decreased insulin secretion
|
J:95636
|
Cacna2d2du-td/Cacna2d2du-td
(involves: DBA/2J)
|
abnormal thymus involution
|
J:12166
|
Cacnb4lh/Cacnb4lh
(B6EiC3Sn a/A-Cacnb4lh/J)
|
abnormal thymus involution
|
J:5281
|
Cacnb4lh/Cacnb4lh
(BALB/cGn-Cacnb4lh)
|
abnormal thymus involution
|
J:12166
|
Cadm1tm1.2Brd/Cadm1tm1.2Brd
(involves: 129S7/SvEvBrd)
|
increased pancreatic beta cell proliferation
|
J:210552
|
Cadps2tm1Bros/Cadps2tm1Bros
(Not Specified)
|
abnormal pancreatic beta cell physiology
|
J:131014
|
abnormal pancreatic somatostatin secretion
|
J:131014
|
decreased insulin secretion
|
J:131014
|
increased glucagon secretion
|
J:131014
|
Cadpstm1Bros/Cadps+
(Not Specified)
|
abnormal adrenal gland secretion
|
J:99762
|
Cadpstm1Bros/Cadps+ Cadps2tm1Bros/Cadps2tm1Bros
(Not Specified)
|
abnormal pancreatic beta cell physiology
|
J:131014
|
decreased insulin secretion
|
J:131014
|
increased glucagon secretion
|
J:131014
|
Cadpstm1Bros/Cadpstm1Bros
(Not Specified)
|
abnormal adrenal gland physiology
|
J:99762
|
abnormal adrenal gland secretion
|
J:99762
|
Cadpstm1Bros/Cadpstm1Bros Cadps2tm1Bros/Cadps2tm1Bros
(Not Specified)
|
abnormal adrenal gland secretion
|
J:136362,
J:263391
|
Cartpttm1Amgn/Cartpttm1Amgn
(involves: 129X1/SvJ * Black Swiss)
|
decreased insulin secretion
|
J:103911
|
Casp1tm1Flv/Casp1tm1Flv Casp4del/Casp4del
(involves: 129S2/SvPas * C57BL/6)
|
decreased thymocyte apoptosis
|
J:24258
|
Casp3tm1Flv/Casp3tm1Flv Casp7tm1Flv/Casp7+
(B6.129S-Casp3tm1Flv Casp7tm1Flv)
|
decreased thymocyte apoptosis
|
J:105496
|
Casp3tm1Flv/Casp3tm1Flv Casp7tm1Flv/Casp7tm1Flv
(B6.129S-Casp3tm1Flv Casp7tm1Flv)
|
decreased thymocyte apoptosis
|
J:105496
|
Casp8tm1.1Raz/Casp8tm1.1Raz Ripk3tm1Vmd/Ripk3tm1Vmd
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
decreased thymocyte apoptosis
|
J:170814
|
Casp9tm1Flv/Casp9tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
abnormal thymocyte apoptosis
|
J:49088
|
Casp9tm1Mak/Casp9tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1))
|
abnormal thymocyte apoptosis
|
J:49087
|
Cbx4tm1.1Gxu/Cbx4tm1.2Gxu Tg(Foxn1-cre)1Tbo/0
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal thymus physiology
|
J:194053
|
Cbx4tm1.2Gxu/Cbx4tm1.2Gxu
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal thymus physiology
|
J:194053
|
Ccdc80tm1Ftrm/Ccdc80tm1Ftrm
(C57BL/6-Ccdc80tm1Ftrm)
|
increased insulin secretion
|
J:189183
|
Ccnt1Gt(RRR115)Byg/Ccnt1Gt(RRR115)Byg
(involves: 129P2/OlaHsd)
|
abnormal thymus physiology
|
J:130071
|
Cd28tm1Pjl/Cd28tm1Pjl Tg(DO11.10)10Dlo/0
(involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)
|
abnormal thymocyte activation
|
J:25536
|
Cd247tm1Mal/Cd247tm1Mal
(involves: C57BL/6)
|
abnormal thymocyte activation
|
J:110847
|
Cd247tm1Mal/Cd247tm1Mal Lcktm1Mak/Lcktm1Mak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal thymocyte activation
|
J:110847
|
Cd247tm2.1Lov/Cd247tm2.1Lov
(Not Specified)
|
decreased thymocyte apoptosis
|
J:192915
|
Cdc73Gt(RRE190)Byg/Cdc73+
(B6.129P2-Cdc73Gt(RRE190)Byg)
|
increased activity of parathyroid
|
J:243366
|
Cdh1tm2Kem/Cdh1tm2Kem Tg(Ins2-cre)23Herr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J)
|
decreased insulin secretion
|
J:196410
|
increased pancreatic beta cell proliferation
|
J:196410
|
Cdk6tm1Phin/Cdk6tm1Phin
(involves: 129S4/SvJae)
|
abnormal thymocyte activation
|
J:144975
|
decreased thymocyte apoptosis
|
J:144975
|
Cdk8tm1a(EUCOMM)Hmgu/Cdk8tm1a(EUCOMM)Hmgu Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
abnormal pancreatic beta cell physiology
|
J:281075
|
increased insulin secretion
|
J:281075
|
increased pancreatic beta cell apoptosis
|
J:281075
|
Cdk8tm1a(EUCOMM)Hmgu/Cdk8tm1a(EUCOMM)Hmgu Tg(Pdx1-cre)6Tuv/0
(involves: C57BL/6N * FVB/N)
|
increased insulin secretion
|
J:281075
|
Cdkal1Gt(6062)Tgen/Cdkal1Gt(6062)Tgen
(involves: C57BL/6 * C57BL/6J * CBA/JNCrj)
|
decreased insulin secretion
|
J:195460
|
Cdkal1tm1.1Tomik/Cdkal1tm1.1Tomik Tg(Ins2-cre)25Mgn/0
(B6.Cg-Cdkal1tm1.1Tomik Tg(Ins2-cre)25Mgn)
|
abnormal insulin secretion
|
J:178248
|
abnormal pancreatic beta cell physiology
|
J:178248
|
decreased insulin secretion
|
J:178248
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
abnormal thymus physiology
|
J:70894
|
Ceacam2tm1Snaj/Ceacam2tm1Snaj
(involves: 129S4/SvJae * C57BL/6)
|
increased insulin secretion
|
J:181979
|
Ceat1CBA/J/Ceat1NOD
(involves: CBA/J * NOD-H2k)
|
abnormal thyroid gland physiology
|
J:77545
|
Ceat1NOD/Ceat1NOD
(involves: CBA/J * NOD-H2k)
|
abnormal thyroid gland physiology
|
J:77545
|
Cebpbtm1.1Maka/Cebpbtm1.1Maka Ins2Akita/Ins2Akita Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NSlc * CBA/J)
|
decreased insulin secretion
|
J:156725
|
Cebpbtm1.1Maka/Cebpbtm1.1Maka Tg(Ins2-cre)23Herr/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA/J)
|
increased insulin secretion
|
J:156725
|
Cflartm1Ywh/Cflartm1Ywh Tg(Lck-cre)548Jxm/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * CBA)
|
increased thymocyte apoptosis
|
J:100558
|
Cftrtm1Unc/Cftrtm1Unc
(involves: 129P2/OlaHsd)
|
abnormal thymus involution
|
J:2079
|
Cgatm1Sac/Cgatm1Sac
(involves: 129S2/SvPas * C57BL/6J)
|
decreased activity of thyroid gland
|
J:28450
|
Chd7Gt(S20-7E1)Sor/Chd7+
(129S1.129S4(B6)-Chd7Gt(S20-7E1)Sor)
|
abnormal pituitary gland physiology
|
J:174086
|
Chgatm1Skmt/Chgatm1Skmt
(involves: 129S1/Sv * C57BL/6J)
|
abnormal adrenal gland physiology
|
J:99805
|
abnormal adrenal gland secretion
|
J:99805
|
Chgbtm1Ribo/Chgbtm1Ribo
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal adrenal gland secretion
|
J:157697
|
Chgbtm1Ribo/Chgbtm1Ribo
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal endocrine pancreas physiology
|
J:157614
|
decreased insulin secretion
|
J:157614
|
Chrm3tm1Jwe/Chrm3+
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased insulin secretion
|
J:91888
|
Chrm3tm1Jwe/Chrm3tm1Jwe
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased glucagon secretion
|
J:91888
|
decreased insulin secretion
|
J:91888
|
Chrm3tm2Jwe/Chrm3tm2Jwe Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
decreased insulin secretion
|
J:129643
|
Cisd2tm1Tfts/Cisd2tm1Tfts
(B6.129S7-Cisd2tm1Tfts)
|
decreased insulin secretion
|
J:148467
|
Clcn2em1Uis/Clcn2+
(C57BL/6N-Clcn2em1Uis)
|
abnormal adrenal gland physiology
|
J:282228
|
Clec16atm1.1Hhak/Clec16atm1.1Hhak Tg(Pdx1-cre)1Herr/0
(involves: C57BL/6 * C57BL/6J * CBA/J * SJL)
|
abnormal pancreatic beta cell physiology
|
J:214528
|
decreased insulin secretion
|
J:214528
|
Clockm1Jt/Clockm1Jt
(involves: C57BL/6J)
|
decreased insulin secretion
|
J:162641
|
Col1a1tm2(tetO-Fosl2,-DsRed)Wag/Col1a1+ Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
decreased insulin secretion
|
J:211215
|
Col5a3tm1Dgr/Col5a3tm1Dgr
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
decreased insulin secretion
|
J:171817
|
increased pancreatic beta cell apoptosis
|
J:171817
|
Cops6Gt(RRI087)Byg/Cops6+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased thymocyte apoptosis
|
J:172038
|
Coro1atm1Jpie/Coro1atm1Jpie
(involves: 129 * C57BL/6)
|
abnormal thymocyte activation
|
J:133258
|
Crhtm2.1Maj/Crhtm2.1Maj Tg(Sim1-cre)1Lowl/?
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
abnormal adrenal gland secretion
|
J:238330
|
Crhtm2.2Maj/Crhtm2.2Maj
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
abnormal adrenal gland secretion
|
J:238330
|
Ctps1tm1c(KOMP)Wtsi/Ctps1tm1c(KOMP)Wtsi Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(B6.Cg-Ctps1tm1c(KOMP)Wtsi Gt(ROSA)26Sortm1(cre/ERT2)Tyj)
|
abnormal thymus physiology
|
J:348981
|
Cyb5r4tm1Hfb/Cyb5r4tm1Hfb
(involves: 129S4/SvJae * BALB/cAnN)
|
decreased insulin secretion
|
J:91486
|
Cyp11a1tm2Bcc/Cyp11a1tm2Bcc
(Not Specified)
|
abnormal adrenal gland physiology
|
J:133007
|
Dach1tm1Krs/Dach1tm1Krs
(involves: 129P2/OlaHsd)
|
decreased pancreatic beta cell proliferation
|
J:166952
|
Dbhtm1Rpa/Dbhtm1Rpa
(involves: 129S7/SvEvBrd * 129/SvCPJ * C57BL/6J)
|
decreased glucagon secretion
|
J:85772
|
Ddotm1Snyd/Ddotm1Snyd
(involves: 129S4/SvJae)
|
abnormal pituitary gland physiology
|
J:106267
|
Del(2Duoxa2-Duoxa1)1Sref/Del(2Duoxa2-Duoxa1)1Sref
(involves: 129S6/SvEvTac * C57BL/6J)
|
iodide oxidation defect
|
J:205165
|
Del(7Ffar2-Ffar3)1Soff/Del(7Ffar2-Ffar3)1Soff
(involves: 129S4/SvJae * C57BL/6)
|
abnormal insulin secretion
|
J:227939
|
Del(MTmt-Tk-mt-Nd5)1Jiha
(involves: C57BL/6J * CBA)
|
increased insulin secretion
|
J:92536
|
Dgkatm1Xpz/Dgkatm1Xpz Dgkztm1Gak/Dgkztm1Gak
(involves: 129 * 129X1/SvJ * C57BL/6)
|
abnormal thymocyte activation
|
J:113564
|
Dhtkd1tm1Zgwg/Dhtkd1tm1Zgwg
(involves: C57BL/6)
|
increased insulin secretion
|
J:267178
|
Dicer1tm1Tara/Dicer1tm1Tara Foxn1tm3(cre)Nrm/Foxn1+
(involves: 129P2/OlaHsd * C57BL/6NHsd)
|
abnormal thymus involution
|
J:180783
|
abnormal thymus physiology
|
J:180783
|
Dio1tm1Vag/Dio1tm1Vag
(involves: 129 * C57BL/6)
|
abnormal thyroid gland physiology
|
J:104508
|
Dnajb9Gt(KST256)Byg/Dnajb9Gt(KST256)Byg Tg(CAG-XBP1*/Venus)#Miur/?
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pancreatic beta cell apoptosis
|
J:226674
|
Dnmt3btm1Enl/Dnmt3btm6Enl
(involves: 129S4/SvJae * C57BL/6)
|
increased thymocyte apoptosis
|
J:106540
|
Dnmt3btm1Enl/Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6)
|
increased thymocyte apoptosis
|
J:106540
|
Dnmt3btm6Enl/Dnmt3btm6Enl
(involves: 129S4/SvJae * C57BL/6)
|
increased thymocyte apoptosis
|
J:106540
|
Dnmt3btm6Enl/Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6)
|
increased thymocyte apoptosis
|
J:106540
|
Dnmt3btm7Enl/Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6)
|
increased thymocyte apoptosis
|
J:106540
|
Dpp4tm1Nwa/Dpp4tm1Nwa
(C57BL/6-Dpp4tm1Nwa)
|
increased insulin secretion
|
J:62709
|
Drd2tm1Ebo/Drd2tm1Ebo
(involves: 129S2/SvPas * C57BL/6)
|
abnormal pituitary gland physiology
|
J:110599
|
hypersecretion of corticosterone
|
J:110599
|
Drd5tm1Sib/Drd5tm1Sib
(involves: 129S4/SvJae * C57BL/6)
|
abnormal adrenal gland physiology
|
J:95908
|
Dtx1tm1.1Mzl/Dtx1tm1.1Mzl Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal thymocyte activation
|
J:151605
|
Dtx1tm1.2Mzl/Dtx1tm1.2Mzl
(B6.129-Dtx1tm1.2Mzl)
|
abnormal thymocyte activation
|
J:151605
|
decreased thymocyte apoptosis
|
J:151605
|
Duox2thyd/Duox2thyd
(B6(129)-Duox2thyd/J)
|
decreased activity of thyroid gland
|
J:121821
|
E2f1tm1Njd/E2f1tm1Njd
(involves: 129S2/SvPas * C57BL/6)
|
decreased insulin secretion
|
J:89720
|
Efnb1tm1.1Jwu/Efnb1tm1.1Jwu Efnb2tm1.1Jwu/Efnb2tm1.1Jwu Tg(Lck-cre)I540Jxm/0
(B6.Cg-Efnb2tm1.1Jwu Efnb1tm1.1Jwu Tg(Lck-cre)I540Jxm)
|
increased thymocyte apoptosis
|
J:178148
|
Egln3tm1Pjr/Egln3tm1Pjr
(involves: 129S/SvEv * Swiss)
|
abnormal adrenal gland secretion
|
J:136034
|
Egr1tm1Pch/Egr1tm1Pch
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal pituitary secretion
|
J:45064
|
Eif2ak3tm1Drc/Eif2ak3tm1Drc
(involves: 129S6/SvEvTac)
|
abnormal insulin secretion
|
J:76661
|
Eif2ak3tm1Dron/Eif2ak3tm1Dron
(involves: 129S6/SvEvTac * Swiss Webster)
|
abnormal pancreatic beta cell physiology
|
J:70005
|
Eif2s1tm1Rjk/Eif2s1tm1Rjk
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased insulin secretion
|
J:70004
|
Elavl1tm1Dkon/Elavl1tm1Dkon Tg(Lck-cre)I57Jxm/0
(B6.Cg-Elavl1tm1Dkon Tg(Lck-cre)I57Jxm)
|
abnormal thymocyte activation
|
J:148866
|
Ero1bGt(P077G11)Wrst/Ero1b+
(involves: 129S2/SvPas * C57BL/6)
|
decreased insulin secretion
|
J:158805
|
Ero1bGt(P077G11)Wrst/Ero1b+ Ins2Akita/Ins2+
(involves: 129S2/SvPas * C57BL/6NSlc)
|
decreased insulin secretion
|
J:158805
|
Ero1bGt(P077G11)Wrst/Ero1bGt(P077G11)Wrst
(involves: 129S2/SvPas * C57BL/6)
|
decreased insulin secretion
|
J:158805
|
Esr1tm1.1Mma/Esr1tm1.1Mma
(involves: 129S2/SvPas * C57BL/6)
|
abnormal thymus physiology
|
J:171276
|
Esr1tm1.1Ohl/Esr1tm1.1Ohl
(involves: 129S2/SvPas * C57BL/6)
|
abnormal thymus physiology
|
J:171276
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd)
|
abnormal pituitary gland physiology
|
J:40607
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal thymus physiology
|
J:111590
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd)
|
decreased insulin secretion
|
J:151012
|
Ets1tm1.1Dds/Ets1+
(129S6/SvEvTac-Ets1tm1.1Dds)
|
decreased thymocyte apoptosis
|
J:121460
|
Ets1tm1.1Dds/Ets1tm1.1Dds
(129S6/SvEvTac-Ets1tm1.1Dds)
|
decreased thymocyte apoptosis
|
J:121460
|
Extl3tm1.1Okam/Extl3tm1Okam Tg(Ins2-cre)#Okam/0
(involves: 129P2/OlaHsd * ICR)
|
decreased insulin secretion
|
J:148348
|
Faddtm2.1Wnt/Faddtm2.1Wnt Tg(Cd4-cre)1Cwi/?
(B6.Cg-Tg(Cd4-cre)1Cwi Faddtm2.1Wnt)
|
abnormal thymocyte apoptosis
|
J:162312
|
Faimtm1Kplm/Faimtm1Kplm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased thymocyte apoptosis
|
J:164184
|
Fam3btm1Bkht/Fam3btm1Bkht
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased insulin secretion
|
J:167823
|
Faslpr/Faslpr
(MRL/Mp-Faslpr)
|
thyroid gland inflammation
|
J:28171
|
Fastm1Cgn/Fastm1Cgn Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Fastm1Cgn)
|
abnormal thymus involution
|
J:114948
|
Fastm1Dlo/Fastm1Dlo
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal thymus involution
|
J:90750
|
Fasntm1Sem/Fasntm1Sem Tg(Ins2-cre)25Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
abnormal pancreatic beta cell physiology
|
J:127482
|
Fem1btm1Jfma/Fem1btm1Jfma
(involves: 129X1/SvJ * C57BL/6)
|
abnormal pancreatic beta cell physiology
|
J:100017
|
decreased insulin secretion
|
J:100017
|
Ffar1tm1Dgen/Ffar1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased amylin secretion
|
J:141957
|
Ffar1tm1Heed/Ffar1tm1Heed
(Not Specified)
|
decreased insulin secretion
|
J:129843
|
Ffar1tm1Lex/Ffar1tm1Lex
(involves: 129 * C57BL/6)
|
decreased insulin secretion
|
J:122092
|
Ffar1tm1Lex/Ffar1tm1Lex
(involves: C57BL/6 * C57BL/6J)
|
abnormal glucagon secretion
|
J:200805
|
Ffar2tm2Soff/Ffar2tm2Soff Ffar3tm2.1Soff/Ffar3tm2.1Soff Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
abnormal insulin secretion
|
J:227939
|
Ffar4tm1.1Mbj/Ffar4tm1.1Mbj
(involves: C57BL/6)
|
abnormal insulin secretion
|
J:211675
|
abnormal pancreatic somatostatin secretion
|
J:211675
|
Fkbp1btm1.1Okam/Fkbp1btm1.1Okam
(ICR.129-Fkbp1btm1.1Okam)
|
decreased insulin secretion
|
J:136192
|
Foxa1tm1Gsc/Foxa1tm1Gsc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal adrenal gland secretion
|
J:53312
|
Foxa1tm1Stf/Foxa1tm1Stf
(Not Specified)
|
decreased insulin secretion
|
J:57493
|
Foxa2tm1Khk/Foxa2tm1Khk
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA)
|
abnormal insulin secretion
|
J:70409
|
Foxm1tm1Rhc/Foxm1tm1Rhc Tg(Pdx1-cre)89.1Dam/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal insulin secretion
|
J:111026
|
decreased pancreatic beta cell proliferation
|
J:111026
|
Foxn1nu/Foxn1tm1.1Dmsu Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129/Sv * C57BL/6 * CBA * SJL)
|
increased thymocyte apoptosis
|
J:159773
|
Foxo1tm1.1Stlp/Foxo1tm1.1Stlp Tg(Lck-cre)1Cwi/0
(involves: 129S4/SvJae)
|
decreased thymocyte apoptosis
|
J:154205
|
Foxo1tm1Rdp/Foxo1tm1Rdp Foxo3tm1Rdp/Foxo3tm1Rdp Foxo4tm1Rdp/Foxo4tm1Rdp Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA/J)
|
abnormal pancreatic beta cell physiology
|
J:215526
|
decreased insulin secretion
|
J:215526
|
Fyntm1Rmp/Fyntm1Rmp
(involves: 129S2/SvPas * C57BL/6)
|
abnormal thymocyte activation
|
J:70886
|
Fyntm1Sor/Fyntm1Sor
(either: 129S7/SvEvBrd-Fyntm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J))
|
abnormal thymocyte activation
|
J:2242
|
Gadd45gip1tm2Kong/Gadd45gip1tm2Kong Tg(Ins2-cre)25Mgn/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
abnormal pancreatic beta cell physiology
|
J:220742
|
decreased insulin secretion
|
J:220742
|
decreased pancreatic beta cell proliferation
|
J:220742
|
Galtm1Wyn/Galtm1Wyn
(129P2-Galtm1Wyn)
|
abnormal pituitary secretion
|
J:78046
|
decreased insulin secretion
|
J:105628
|
Galtm1Wyn/Galtm1Wyn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pituitary secretion
|
J:84420
|
Gasttm1(INS)Ez/Gast+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal insulin secretion
|
J:99270
|
Gata2tm1Sac/Gata2tm1Sac Tg(Cga-cre)3Sac/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL)
|
abnormal pituitary secretion
|
J:108963
|
Gctm1Nec/Gctm1Nec
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased activity of parathyroid
|
J:52225
|
Gcgrem2Smoc/Gcgrem2Smoc
(C57BL/6J-Gcgrem2Smoc)
|
increased pancreatic alpha cell proliferation
|
J:300368
|
Gcgrtm1Jcp/Gcgrtm1Jcp
(DBA/1LacJ-Gcgrtm1Jcp)
|
increased pancreatic beta cell proliferation
|
J:176507
|
Gcgrtm1Mjch/Gcgrtm1Mjch
(involves: 129 * C57BL/6J * SJL)
|
increased glucagon secretion
|
J:208604
|
increased pancreatic alpha cell proliferation
|
J:208604
|
Gcgrtm2.1Mjch/Gcgrtm2.1Mjch Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA * SJL)
|
increased pancreatic alpha cell proliferation
|
J:208604
|
GckGls006/Gck+
(C3HeB/FeJ-GckGls006)
|
decreased insulin secretion
|
J:189544
|
Gckm1Rge/Gck+
(involves: C3HeB/FeJ)
|
decreased insulin secretion
|
J:162903
|
Gcktm1.1Mgn/Gck+ Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
decreased insulin secretion
|
J:51826
|
Gcktm1.1Mgn/Gcktm1.1Mgn Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
decreased insulin secretion
|
J:51826
|
Gcktm1.2Mgn/Gck+
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased insulin secretion
|
J:51826
|
Gcktm1Hrt/Gck+ Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * DBA)
|
abnormal pancreatic beta cell physiology
|
J:250069
|
Gcktm1Tka/Gck+
(involves: 129X1/SvJ * ICR)
|
decreased insulin secretion
|
J:30334
|
Gcktm1Tka/Gcktm1Tka
(involves: 129X1/SvJ * ICR)
|
abnormal pancreatic beta cell physiology
|
J:30334
|
decreased insulin secretion
|
J:30334
|
Gcktm1Ydor/Gck+ Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * C57BL/6J * DBA)
|
abnormal endocrine pancreas physiology
|
J:302600
|
abnormal pancreatic beta cell physiology
|
J:302600
|
increased insulin secretion
|
J:302600
|
increased pancreatic beta cell proliferation
|
J:302600
|
Gcktm2Mgn/Gck+
(129S6/SvEvTac-Gcktm2Mgn)
|
abnormal insulin secretion
|
J:121910
|
Gcktm3Mgn/Gck+
(129S6/SvEvTac-Gcktm3Mgn)
|
abnormal insulin secretion
|
J:121910
|
Gcktm3Mgn/Gcktm3Mgn
(129S6/SvEvTac-Gcktm3Mgn)
|
abnormal insulin secretion
|
J:121910
|
Gcm2tm1Kry/Gcm2tm1Kry
(involves: 129S7/SvEvBrd)
|
decreased activity of parathyroid
|
J:63291
|
Gemtm1.1Jgun/Gemtm1.1Jgun
(involves: BALB/c * C57BL/6)
|
abnormal pancreatic beta cell physiology
|
J:187922
|
decreased insulin secretion
|
J:187922
|
Gfra4tm1Msa/Gfra4tm1Msa
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6JOlaHsd)
|
abnormal thyroid gland physiology
|
J:108404
|
Ghrtm1.1Dlr/Ghrtm1.1Dlr Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
decreased pancreatic beta cell proliferation
|
J:284574
|
Ghrtm1.1Dlr/Ghrtm1.1Dlr Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C3H * C57BL/6 * DBA)
|
decreased insulin secretion
|
J:173909
|
decreased pancreatic beta cell proliferation
|
J:173909
|
Ghrtm1Jjk/Ghrtm1Jjk
(involves: 129P2/OlaHsd * BALB/c * C3H * C57BL/6)
|
decreased activity of thyroid gland
|
J:103286
|
Ghrltm1Mko/Ghrltm1Mko
(B6.Cg-Ghrltm1Mko)
|
increased insulin secretion
|
J:121019
|
Gjd2tm1Kwi/Gjd2tm1Kwi
(involves: 129P2/OlaHsd)
|
decreased insulin secretion
|
J:117402
|
Gjd2tm1Kwi/Gjd2tm1Kwi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal insulin secretion
|
J:122093
|
abnormal pancreatic beta cell physiology
|
J:122093
|
Gjd2tm4Kwi/Gjd2tm4Kwi Tg(Ins2-cre)23Herr/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal pancreatic beta cell physiology
|
J:174834
|
increased insulin secretion
|
J:174834
|
Gktm1Wjc/Y
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal pituitary secretion
|
J:43449
|
Glis3tm1.2Chan/Glis3+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
decreased insulin secretion
|
J:177082
|
Glis3tm1.2Chan/Glis3tm1.2Chan
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
decreased insulin secretion
|
J:177082
|
Glis3tm1Hiha/Glis3tm1Hiha
(involves: C57BL/6 * CBA)
|
decreased activity of thyroid gland
|
J:150077
|
Gluchos1C57BL/6J/Gluchos1C57BL/6J
(C57BL/6J)
|
decreased insulin secretion
|
J:109356
|
Glud1tm1.1Pma/Glud1tm1.1Pma
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased insulin secretion
|
J:145558
|
Glud1tm1.1Pma/Glud1tm1.1Pma Tg(Ins2-cre)23Herr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA/J * SJL)
|
decreased insulin secretion
|
J:145558
|
Gna11tm1Soff/Gna11tm1Soff Gnaqtm2Soff/Gnaqtm2Soff Tg(Tg-cre)1Soff/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal thyroid gland physiology
|
J:127484
|
decreased activity of thyroid gland
|
J:127484
|
Gnao1tm3Lbi/Gnao1tm3Lbi
(involves: 129S7/SvEvBrd)
|
increased insulin secretion
|
J:168245
|
Gnao1tm4Lbi/Gnao1tm4Lbi Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA)
|
abnormal pancreatic beta cell physiology
|
J:169627
|
increased insulin secretion
|
J:169627
|
Gnrh1hpg/Gnrh1hpg
(involves: 101/H * C3H/HeH)
|
abnormal pituitary gland physiology
|
J:5877
|
Gnrhrtm2.1(GNRHR)Djb/Gnrhrtm2.1(GNRHR)Djb
(involves: 129 * C57BL/6J * FVB/N)
|
abnormal pituitary gland physiology
|
J:324870
|
Gpcpd1tm1c(EUCOMM)Hmgu/Gpcpd1tm1c(EUCOMM)Hmgu Tg(Ckmm-cre)5Khn/0
(involves: C57BL/6J * C57BL/6N * FVB)
|
increased insulin secretion
|
J:345630
|
Gpd2tm1Tka/Gpd2tm1Tka
(involves: C57BL/6 * CBA)
|
decreased insulin secretion
|
J:75839
|
Gper1tm1.1Lmlf/Gper1tm1.1Lmlf
(B6.129-Gper1tm1.1Lmlf)
|
decreased glucagon secretion
|
J:146345
|
decreased insulin secretion
|
J:146345
|
Gpr27tm1Tac/Gpr27tm1Tac
(B6.129S-Gpr27tm1Tac)
|
abnormal endocrine pancreas physiology
|
J:286854
|
decreased insulin secretion
|
J:286854
|
Gpr68tm1.1Aha/Gpr68tm1.1Aha
(B6.129(C)-Gpr68tm1.1Aha)
|
decreased insulin secretion
|
J:189192
|
Gpr68tm1Aha/Gpr68tm1Aha
(B6.129-Gpr68tm1Aha)
|
decreased insulin secretion
|
J:189192
|
Gpr142tm1Lex/Gpr142tm1Lex
(B6.129S-Gpr142tm1Lex)
|
decreased insulin secretion
|
J:249154
|
Grb10tm1.1Fliu/Grb10tm1.1Fliu Tg(Pdx1-cre)6Tuv/0
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
abnormal pancreatic beta cell physiology
|
J:208498
|
increased insulin secretion
|
J:208498
|
increased pancreatic beta cell proliferation
|
J:208498
|
Gsk3btm1Jrw/Gsk3b+ Irs2tm1Mfw/Irs2tm1Mfw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased pancreatic beta cell proliferation
|
J:135659
|
Gsx1tm1Ssp/Gsx1tm1Ssp
(involves: 129P2/OlaHsd)
|
abnormal pituitary secretion
|
J:31764
|
Gt(ROSA)26Sortm1(CAG-Foxn1/ERT2,-GFP)Cbln/Gt(ROSA)26Sor+ Foxn1tm3(cre)Nrm/Foxn1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal thymus involution
|
J:208852
|
Gt(ROSA)26Sortm1(CAG-Kcnj11*,-GFP)Nich/Gt(ROSA)26Sor+ Tg(Ins2-cre)23Herr/0
(involves: C57BL/6 * CBA/J)
|
abnormal pancreatic beta cell physiology
|
J:146650
|
decreased insulin secretion
|
J:146650
|
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+ Secisbp2tm1.1Amdu/Secisbp2tm1.2Amdu
(B6(129S4)-Gt(ROSA)26Sortm1(cre/ERT2)Tyj Secisbp2tm1.1Amdu Secisbp2tm1.2Amdu)
|
abnormal pituitary gland physiology
|
J:251875
|
Gt(ROSA)26Sortm1(DTA)Vlcg/Gt(ROSA)26Sortm1(DTA)Vlcg Tg(BGLAP-cre/ERT2)#Stko/0
(involves: 129S1/Sv * FVB/N)
|
decreased insulin secretion
|
J:201507
|
decreased pancreatic beta cell proliferation
|
J:201507
|
Gt(ROSA)26Sortm1(Gck)Ydor/Gt(ROSA)26Sor+ Tg(Pdx1-cre/Esr1*)#Dam/0
(involves: C57BL/6 * CBA)
|
abnormal pancreatic beta cell physiology
|
J:210493
|
decreased pancreatic beta cell proliferation
|
J:210493
|
Gt(ROSA)26Sortm1(Gck)Ydor/Gt(ROSA)26Sortm1(Kcnj11*V59M)Fmas Tg(Pdx1-cre/Esr1*)#Dam/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal pancreatic beta cell physiology
|
J:210493
|
Gt(ROSA)26Sortm1(Kcnj11*V59M)Fmas/Gt(ROSA)26Sor+ Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6)
|
abnormal pancreatic beta cell physiology
|
J:144715
|
decreased insulin secretion
|
J:144715
|
Gt(ROSA)26Sortm1(Mir7-1,-EGFP)Horn/Gt(ROSA)26Sor+ Tg(Pdx1-cre)89.1Dam/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6J * CBA)
|
decreased glucagon secretion
|
J:187631
|
decreased insulin secretion
|
J:187631
|
Gt(ROSA)26Sortm1.1(CAG-Trp53*,-EGFP)Medz/Gt(ROSA)26Sortm1.1(CAG-Trp53*,-EGFP)Medz
(involves: C57BL/6)
|
decreased thymocyte apoptosis
|
J:158953
|
Gt(ROSA)26Sortm1.1(Mir26a-1)Coh/Gt(ROSA)26Sor+ Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA)
|
decreased insulin secretion
|
J:286108
|
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+ Tg(MMTV-cre)4Mam/0
(involves: C57BL/6J * C57BL/6N * FVB/N)
|
abnormal thymus physiology
|
J:202090
|
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+ Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA)
|
abnormal thymus physiology
|
J:202090
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell/Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell
(NOD.Cg-H2-Ab1b-tm1Gru Tg(CD4,HLA-DQA1,HLA-DQB1)N8Ell)
|
thyroid gland inflammation
|
J:113509
|
H2b/H2b Nfkbidtm1Clay/Nfkbidtm1Clay Rag2tm1Fwa/Rag2tm1Fwa Tg(TcraN15,TcrbN15)L2Elre/?
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6)
|
abnormal thymocyte activation
|
J:132071
|
H2h4/H2h4
(NOD.Cg-H2h4)
|
thyroid gland inflammation
|
J:54563
|
HadhGt(RRM279)Byg/HadhGt(RRM279)Byg
(B6.129P2-HadhGt(RRM279)Byg)
|
increased insulin secretion
|
J:179084
|
Hdac1tm1.1Shmc/Hdac1tm1.1Shmc Hdac2tm1.1Shmc/Hdac2tm1.1Shmc Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd)
|
increased thymocyte apoptosis
|
J:194769
|
Hhiptm1Amc/Hhiptm1Amc
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased pancreatic beta cell proliferation
|
J:85472
|
Hint2tm1.1Geno/Hint2tm1.1Geno
(involves: 129S2/SvPas * C57BL/6J)
|
decreased insulin secretion
|
J:237329
|
Hipk3Gt(OST51087)Lex/Hipk3Gt(OST51087)Lex
(involves: 129S5/SvEvBrd)
|
abnormal pancreatic beta cell physiology
|
J:194563
|
decreased insulin secretion
|
J:194563
|
decreased pancreatic beta cell proliferation
|
J:194563
|
Hipq1C57BL/6Wehi/Hipq1C57BL/6Wehi
(involves: C57BL/6Wehi * DBA/2Wehi)
|
decreased insulin secretion
|
J:129498
|
Hipq1DBA/2Wehi/Hipq1DBA/2Wehi
(involves: C57BL/6Wehi * DBA/2Wehi)
|
increased insulin secretion
|
J:129498
|
Hmga1tm1Brun/Hmga1+
(Not Specified)
|
decreased insulin secretion
|
J:99652
|
Hmga1tm1Brun/Hmga1tm1Brun
(Not Specified)
|
decreased insulin secretion
|
J:99652
|
Hnf1atm1Mya/Hnf1atm1Mya
(involves: 129S2/SvPas)
|
decreased insulin secretion
|
J:48230
|
Hnf1btm2Ics/Hnf1b+
(involves: 129 * C57BL/6N)
|
decreased insulin secretion
|
J:306082
|
Hpntm1Qwu/Hpntm1Qwu
(involves: 129X1/SvJ * NIH Swiss)
|
decreased activity of thyroid gland
|
J:123922
|
Hprt1tm1(Ins2-HBEGF)Herr/Y
(involves: 129 * C57BL/6)
|
abnormal pancreatic beta cell physiology
|
J:159291
|
decreased insulin secretion
|
J:159291
|
increased insulin secretion
|
J:159291
|
HrUSP/HrUSP
(either: (involves: A/J * BALB/c) or (involves: BALB/c * C57BL/6) or (involves: BALB/c * DBA/2))
|
abnormal thymus involution
|
J:21316
|
Htr2btm1Kry/Htr2btm1Kry Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * CBA/J)
|
decreased pancreatic beta cell proliferation
|
J:284574
|
Ier3ip1tm1Arvn/Ier3ip1tm1Arvn Tg(Ins1-cre/ERT)1Lphi/0
(involves: 129S4/SvJaeSor * C57BL/6J * CD-1)
|
decreased insulin secretion
|
J:336782
|
decreased pancreatic beta cell proliferation
|
J:336782
|
increased pancreatic beta cell apoptosis
|
J:336782
|
Ier3ip1tm1Arvn/Ier3ip1tm1Arvn Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * C57BL/6J * DBA)
|
decreased insulin secretion
|
J:336782
|
decreased pancreatic beta cell proliferation
|
J:336782
|
increased pancreatic beta cell apoptosis
|
J:336782
|
Ifngtm1Ts/Ifngtm1Ts
(NOD.129S7(B6)-Ifngtm1Ts/DvsJ)
|
abnormal pancreatic beta cell physiology
|
J:72818
|
Igfbp3tm1Jep/Igfbp3tm1Jep Igfbp4tm1Jep/Igfbp4tm1Jep Igfbp5tm1Jep/Igfbp5tm1Jep
(involves: 129S/SvEv * C57BL/6J)
|
increased insulin secretion
|
J:112029
|
Igs2em5(CAG-Mir802)Gpt/Igs2em5(CAG-Mir802)Gpt Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6JGpt * DBA)
|
decreased insulin secretion
|
J:287584
|
Igsf1tm1Zuk/Y
(either: (involves: 129S6/SvEv * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6J))
|
decreased activity of thyroid gland
|
J:190867
|
Ikzf1tm1Kge/Ikzf1+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal thymocyte activation
|
J:29355
|
Ikzf1tm1Kge/Ikzf1+
(involves: 129S4/SvJae * BALB/c)
|
abnormal thymocyte activation
|
J:29355
|
Il2tm1Hor/Il2tm1Hor
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal thymocyte activation
|
J:37220,
J:39989
|
Il2rgtm1Cgn/Y
(involves: 129 * CB20)
|
abnormal thymocyte activation
|
J:22521
|
Il2rgtm1Cgn/Il2rgtm1Cgn
(involves: 129 * CB20)
|
abnormal thymocyte activation
|
J:22521
|
Il2rgtm1Wjl/Y
(involves: 129S4/SvJae * C57BL/6)
|
abnormal thymocyte activation
|
J:24117
|
Il6tm1Kopf/Il6tm1Kopf
(B6.129S2-Il6tm1Kopf/J)
|
decreased glucagon secretion
|
J:139138
|
decreased insulin secretion
|
J:139138
|
Il6ratm1.1Jcbr/Il6ratm1.1Jcbr Tg(Alb1-cre)7Gsc/0
(involves: C57BL/6 * FVB/N)
|
decreased insulin secretion
|
J:166367
|
increased insulin secretion
|
J:166367
|
Il6sttm1Kish/Il6sttm1Kish
(involves: 129P2/OlaHsd * CD-1)
|
increased activity of parathyroid
|
J:88710
|
Il6sttm1Thir/Il6sttm1Thir
(involves: 129 * C57BL/6)
|
abnormal thymocyte activation
|
J:133059
|
Il7rtm1Imx/Il7rtm1Imx Tg(Lck-Il7r)1676Trma/?
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
increased thymocyte apoptosis
|
J:66400
|
Il10tm1Cgn/Il10tm1Cgn Vdrtm1Mbd/Vdrtm1Mbd
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal thymus involution
|
J:107077
|
Il15ratm1.1Nsl/Il15ratm1.1Nsl
(involves: 129X1/SvJ * C57BL/6)
|
increased thymocyte apoptosis
|
J:73738
|
Il21rtm1Day/Il21rtm1Day
(involves: BALB/c * C57BL/6)
|
abnormal thymocyte activation
|
J:76043
|
Ilruntm1a(KOMP)Wtsi/Ilruntm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
decreased insulin secretion
|
J:302091
|
Ing1Gt(OST206270)Lex/Ing1Gt(OST206270)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased thymocyte apoptosis
|
J:118602
|
Ins1tm1Jja/Ins1tm1Jja Ins2tm1Jja/Ins2tm1Jja
(involves: 129S2/SvPas * C57BL/6)
|
increased pancreatic alpha cell proliferation
|
J:106827
|
increased pancreatic beta cell proliferation
|
J:106827
|
Ins1tm1Jja/Ins1tm1Jja Ins2tm1Mnt/Ins2tm1Mnt Tg(Aire-cre)1Mnt/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
abnormal pancreatic beta cell physiology
|
J:152798
|
Ins2Akita/Ins2+
(C57BL/6-Ins2Akita)
|
decreased insulin secretion
|
J:40063,
J:47883
|
Ins2Akita/Ins2+
(involves: C57BL/6NSlc)
|
decreased insulin secretion
|
J:200802
|
Ins2Akita/Ins2+ Rnf213tm1.1Akoi/Rnf213tm1.1Akoi
(involves: C57BL/6N * C57BL/6NSlc)
|
decreased insulin secretion
|
J:200802
|
Ins2Akita/Ins2Akita
(C57BL/6-Ins2Akita)
|
decreased insulin secretion
|
J:47883
|
Ins2Akita/Ins2Akita
(involves: C57BL/6NSlc)
|
decreased insulin secretion
|
J:156725
|
Ins2Akita/Ins2Akita Jazf1tm1c(EUCOMM)Wtsi/Jazf1tm1c(EUCOMM)Wtsi Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJaeSor * C57BL/6N * C57BL/6NSlc * CBA/J)
|
decreased pancreatic beta cell proliferation
|
J:303318
|
increased pancreatic beta cell apoptosis
|
J:303318
|
Ins2C95S/Ins2+
(C3HeB/FeJ-Ins2C95S)
|
abnormal pancreatic beta cell physiology
|
J:122098
|
decreased insulin secretion
|
J:122098
|
Ins2tm1Jja/Ins2tm1Jja
(involves: 129S2/SvPas)
|
increased insulin secretion
|
J:77595
|
Insm1tm1.1(GFP/cre)Mgn/Insm1tm1.1(GFP/cre)Mgn
(involves: 129S6/SvEvTac * CD-1 * SJL)
|
abnormal pancreatic endocrine progenitor cell physiology
|
J:214095
|
decreased pancreatic endocrine progenitor cell proliferation
|
J:214095
|
InsrM2Btlr/InsrM2Btlr
(C57BL/6J-InsrM2Btlr)
|
increased insulin secretion
|
J:267535
|
Insrtm1Dac/Insr+
(involves: C3H/HeH * C57BL/6)
|
increased insulin secretion
|
J:141688
|
Insrtm1Khn/Insrtm1Khn Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6J * DBA/2 * FVB)
|
increased insulin secretion
|
J:63878
|
Insrtm1Khn/Insrtm1Khn Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+ Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
decreased insulin secretion
|
J:121640
|
Insrtm1Khn/Insrtm1Khn Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
decreased insulin secretion
|
J:121640
|
Irs1tm1Tka/Irs1tm1Tka
(involves: C57BL/6 * CBA)
|
decreased insulin secretion
|
J:65485
|
Irs2M1Btlr/Irs2M1Btlr
(C57BL/6J-Irs2M1Btlr)
|
increased insulin secretion
|
J:267533
|
Irs2tm1Tka/Irs2tm1Tka
(involves: C57BL/6 * CBA)
|
increased insulin secretion
|
J:65485
|
Itpkbtm1Ssch/Itpkbtm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal thymocyte activation
|
J:86257
|
abnormal thymus involution
|
J:86257
|
Itpkbtm1Ssch/Itpkbtm1Ssch Itpkctm1Ssch/Itpkctm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal thymocyte activation
|
J:86257
|
Itpr1opt/Itpr1+
(B6C3Fe-a/a-Itpr1opt/J)
|
decreased insulin secretion
|
J:222913
|
Itsn1tm1.1Mapr/Itsn1tm1.1Mapr
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal adrenal gland secretion
|
J:140030
|
Itsn1tm2.1Mapr/Itsn1tm2.1Mapr
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal adrenal gland secretion
|
J:140030
|
Jazf1tm1c(EUCOMM)Wtsi/Jazf1tm1c(EUCOMM)Wtsi Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJaeSor * C57BL/6N * CBA/J)
|
abnormal endocrine pancreas physiology
|
J:303318
|
Kalrntm2.1Npl/Kalrntm2.1Npl
(B6.Cg-Kalrntm2.1Npl)
|
abnormal pituitary secretion
|
J:206512
|
acromegaly
|
J:206512
|
Kcnb1tm1Dgen/Kcnb1tm1Dgen
(involves: C57BL/6)
|
abnormal pancreatic beta cell physiology
|
J:129963
|
increased insulin secretion
|
J:129963
|
Kcnh6em1Jkya/Kcnh6em1Jkya
(involves: C57BL/6N)
|
abnormal insulin secretion
|
J:271003
|
abnormal pancreatic beta cell physiology
|
J:271003
|
decreased insulin secretion
|
J:271003
|
increased insulin secretion
|
J:271003
|
Kcnh6em2Jkya/Kcnh6em2Jkya
(involves: C57BL/6N)
|
abnormal pancreatic beta cell physiology
|
J:271003
|
decreased insulin secretion
|
J:271003
|
Kcnj11tm1Sse/Kcnj11+ Tg(Ins1-Kcnj11*)#Nich/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal pancreatic beta cell physiology
|
J:94610
|
decreased insulin secretion
|
J:94610
|
increased insulin secretion
|
J:94610
|
Kcnj11tm1Sse/Kcnj11tm1Sse
(B6.129P2-Kcnj11tm1Sse)
|
decreased glucagon secretion
|
J:69163
|
Kcnj11tm1Sse/Kcnj11tm1Sse Tg(Ins1-Kcnj11*)#Nich/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased insulin secretion
|
J:94610
|
Kcnj11Y12stop/Kcnj11Y12stop
(involves: BALB/c * C3H/HeH)
|
decreased glucagon secretion
|
J:122088
|
increased insulin secretion
|
J:122088
|
Kcnk3tm1.1Daba/Kcnk3tm1.1Daba Kcnk9tm1.1Daba/Kcnk9tm1.1Daba
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal adrenal gland physiology
|
J:131927
|
Kcnk16tm1.1Lex/Kcnk16tm1.1Lex
(B6.129S-Kcnk16tm1.1Lex)
|
abnormal pancreatic beta cell physiology
|
J:259519
|
increased insulin secretion
|
J:259519
|
Kif5btm1Njen/Kif5b+ Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6N * DBA * SJL)
|
decreased insulin secretion
|
J:170198
|
Kif5btm1Njen/Kif5btm1.1Njen Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6N * DBA * SJL)
|
abnormal pancreatic beta cell physiology
|
J:170198
|
decreased insulin secretion
|
J:170198
|
Klkl/Kl+
(involves: C3H/HeJ * C57BL/6J)
|
decreased insulin secretion
|
J:64878
|
Klkl/Klkl
(either: C.Cg-Klkl or (involves: C3H/HeJ * C57BL/6J))
|
decreased insulin secretion
|
J:44109
|
Klkl/Klkl
(involves: C3H/HeJ * C57BL/6J)
|
decreased insulin secretion
|
J:64878
|
Klf13tm1Kren/Klf13tm1Kren
(B6.129-Klf13tm1Kren)
|
decreased thymocyte apoptosis
|
J:145839
|
Kmt2bGena263/Kmt2b+
(involves: BALB/c * C3H/HeH)
|
decreased insulin secretion
|
J:203736
|
Kmt2bm1H/Kmt2b+
(involves: BALB/c * C3H/HeH)
|
decreased insulin secretion
|
J:203736
|
Kmt2btm1Afst/Kmt2b+
(involves: 129P2/OlaHsd)
|
decreased insulin secretion
|
J:203736
|
Lama2tm1Stk/Lama2tm1Stk
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal thymus physiology
|
J:61802
|
Lamtor5tm1Lye/Lamtor5tm1Lye
(Not Specified)
|
decreased insulin secretion
|
J:258406
|
Lamtor5tm1Lye/Lamtor5tm1Lye Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA)
|
decreased insulin secretion
|
J:258406
|
Lattm2.1Mal/Lattm2.1Mal
(involves: 129S2/SvPas)
|
abnormal thymocyte activation
|
J:94074
|
Lattm3.1Mal/Lattm3.1Mal
(involves: 129S2/SvPas)
|
abnormal thymocyte activation
|
J:94074
|
Lattm4.1Mal/Lattm4.1Mal
(involves: 129P2/OlaHsd)
|
abnormal thymocyte activation
|
J:94074
|
Lcktm1Mak/Lcktm1Mak
(involves: 129S2/SvPas)
|
abnormal thymocyte activation
|
J:110847
|
Lcn2tm1Mrgr/Lcn2tm1Mrgr
(129(B6)-Lcn2tm1Mrgr)
|
decreased thymocyte apoptosis
|
J:173490
|
Lcp2tm3Gak/Lcp2tm3Gak Tg(TcrAND)53Hed/?
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal thymocyte activation
|
J:132995
|
Lcp2tm4Gak/Lcp2tm4Gak Tg(TcrAND)53Hed/?
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal thymocyte activation
|
J:132995
|
Lcp2tm5(Lat/Lcp2)Gak/Lcp2tm5(Lat/Lcp2)Gak
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal thymocyte activation
|
J:147721
|
Lepob/Lepob
(involves: C57BL/6J)
|
abnormal insulin secretion
|
J:14402,
J:22634
|
Lepob/Lepob
(B6.Cg-Lepob/J)
|
abnormal pancreatic beta cell physiology
|
J:5400
|
decreased insulin secretion
|
J:145998
|
increased insulin secretion
|
J:145998
|
Lepob/Lepob
(involves: 129 * C57BL/6)
|
increased insulin secretion
|
J:121534
|
Lepob/Lepob
(BKS.Cg-Lepob/J)
|
abnormal pancreatic beta cell physiology
|
J:5400
|
Lepob/Lepob
(involves: STOCK Mlphln a Tgfawa1 Cdh23v Ednrbs)
|
decreased activity of thyroid gland
|
J:7702
|
hypersecretion of corticosterone
|
J:7702
|
Lepob/Lepob Ppargtm2Avp/Ppargtm2Avp
(involves: 129 * C57BL/6)
|
abnormal insulin secretion
|
J:121534
|
Lepob/Lepob Tg(Ins2-Mir184)4Mnpy/0
(involves: C57BL/10J)
|
decreased insulin secretion
|
J:210552
|
Leprdb/Leprdb
(involves: C57BLKS/J)
|
abnormal pancreatic beta cell physiology
|
J:210493
|
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb/J)
|
increased glucagon secretion
|
J:6264
|
Leprdb/Leprdb Ptentm1Hwu/Ptentm1Hwu Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * C57BLKS/J * DBA)
|
increased insulin secretion
|
J:170206
|
Leprtm1.1Chua/Leprtm1.1Chua Tg(Syn1-cre)671Jxm/0
(involves: 129 * C57BL/6 * CBA)
|
increased insulin secretion
|
J:145998
|
Leprtm1Jke/Leprtm1Jke
(involves: 129X1/SvJ * C57BL/6J)
|
increased insulin secretion
|
J:184572
|
Leprtm1Jke/Leprtm1Jke Tg(Pomc1-cre)16Lowl/0
(involves: 129X1/SvJ * C57BL/6J * FVB/N)
|
increased insulin secretion
|
J:184572
|
Leprtm2Mgmj/Leprtm2Mgmj
(Not Specified)
|
decreased insulin secretion
|
J:145998
|
Leprtm5Mgmj/Leprtm5Mgmj
(B6.129-Leprtm5Mgmj)
|
abnormal insulin secretion
|
J:221245
|
Lhx3tm1.1Sjr/Lhx3tm1.1Sjr
(involves: 129S/SvEv * C57BL/6J * FVB/N)
|
decreased activity of thyroid gland
|
J:169035
|
Lig1tm3Dwm/Lig1tm3Dwm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal thymus physiology
|
J:77902
|
Lipetm2Rze/Lipetm2Rze Tg(Ins2-cre)25Mgn/?
(involves: 129 * C57BL/6 * DBA)
|
abnormal insulin secretion
|
J:144744
|
Lpin1fld/Lpin1fld
(BALB/cByJ-Lpin1fld)
|
decreased insulin secretion
|
J:63448
|
Lrp5tm1Jsak/Lrp5tm1Jsak
(involves: C57BL/6 * CBA)
|
decreased insulin secretion
|
J:81174
|
Lrpap1tm1Her/Lrpap1tm1Her
(B6.129S7-Lrpap1tm1Her)
|
abnormal thyroid gland physiology
|
J:107358
|
Lrrc8atm1.1Geha/Lrrc8atm1.1Geha
(B6.129S1(Cg)-Lrrc8atm1.1Geha)
|
abnormal thymus apoptosis
|
J:211308
|
abnormal thymus physiology
|
J:211308
|
increased thymocyte apoptosis
|
J:211308
|
Lrrk2tm1.1Shn/Lrrk2tm1.1Shn
(involves: 129 * C57BL/6)
|
abnormal adrenal gland secretion
|
J:151944
|
Ly6etm1Zmt/Ly6etm1Zmt
(involves: 129S1/Sv)
|
failure of adrenal epinephrine secretion
|
J:73972
|
Maddtm1Bpra/Maddtm1Bpra Tg(Ins2-cre/ERT)1Dam/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal pancreatic beta cell physiology
|
J:225256
|
decreased insulin secretion
|
J:225256
|
Mafatm1Staka/Mafatm1Staka
(involves: ICR)
|
decreased insulin secretion
|
J:99126
|
Map2k6tm1Flv/Map2k6tm1Flv
(involves: 129S1/Sv)
|
abnormal thymocyte apoptosis
|
J:85266
|
Map3k7tm1Zjc/Map3k7tm1Zjc Tg(Lck-cre)548Jxm/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
increased thymocyte apoptosis
|
J:111794
|
Mapk8tm1.1Jcbr/Mapk8tm1.1Jcbr
(involves: 129S4/SvJae * C57BL/6)
|
decreased insulin secretion
|
J:195844
|
Mapk8tm1Rjd/Mapk8tm1Rjd Mapk9tm2.1Rjd/Mapk9tm2.1Rjd Lyz2tm1(cre)Ifo/Lyz2+
(B6J.Cg-Lyz2tm1(cre)Ifo Mapk9tm2.1Rjd Mapk8tm1Rjd)
|
decreased pancreatic beta cell proliferation
|
J:192551
|
increased insulin secretion
|
J:192551
|
Mapk13tm2.1Lex/Mapk13tm2.1Lex
(B6.129S5-Mapk13tm2.1Lex)
|
abnormal pancreatic beta cell physiology
|
J:146185
|
increased insulin secretion
|
J:146185
|
Mapk14tm1.1Dvb/Mapk14+
(B6(FVB)-Mapk14tm1.1Dvb)
|
decreased pancreatic beta cell proliferation
|
J:151980
|
increased pancreatic beta cell proliferation
|
J:151980
|
Mdm2tm2.1Snj/Mdm2tm2.1Snj
(involves: 129S4/SvJae * C57BL/6)
|
decreased thymocyte apoptosis
|
J:189297
|
Mdm4tm1.1Wahl/Mdm4tm1.1Wahl
(involves: 129S/Sv * C57BL/6)
|
decreased thymocyte apoptosis
|
J:150341
|
Med1tm1Rgr/Med1+
(either: 129X1/SvJ or (involves: 129X1/SvJ * C57BL/6J))
|
decreased activity of thyroid gland
|
J:61840
|
Mettm1Sst/Mettm1Sst Tg(Pdx1-cre)89.1Dam/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal pancreatic beta cell physiology
|
J:196854
|
decreased insulin secretion
|
J:196854
|
decreased pancreatic beta cell proliferation
|
J:196854
|
Mir26a-1em1Xfu/Mir26a-1em1Xfu Mir26a-2em1Xfu/Mir26a-2em1Xfu
(involves: C57BL/6)
|
increased pancreatic beta cell proliferation
|
J:286108
|
Mir184tm1Ics/Mir184tm1Ics
(Not Specified)
|
increased insulin secretion
|
J:210552
|
increased pancreatic beta cell proliferation
|
J:210552
|
Mir375tm1Stf/Mir375tm1Stf
(B6.129-Mir375tm1Stf)
|
increased glucagon secretion
|
J:147572
|
increased insulin secretion
|
J:147572
|
Mir802em3Gpt/Mir802em3Gpt Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6JGpt * DBA)
|
increased insulin secretion
|
J:287584
|
Mirc13tm1Biat/Mirc13+ Mirc4tm1.1Biat/Mirc4tm1.1Biat Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
abnormal pancreatic beta cell apoptosis
|
J:314874
|
Mirc13tm1Biat/Mirc13tm1Biat
(involves: C57BL/6J * C57BL/6N)
|
abnormal pancreatic beta cell apoptosis
|
J:314874
|
Mirc13tm1Biat/Mirc13tm1Biat Mirc4tm1.1Biat/Mirc4tm1.1Biat Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
abnormal pancreatic beta cell apoptosis
|
J:314874
|
Mirc14tm1.2Flv/Mirc14tm1.2Flv
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
decreased thymocyte apoptosis
|
J:203157
|
Mirc33em1Smoc/Mirc33em1Smoc
(Not Specified)
|
abnormal pituitary gland physiology
|
J:324059
|
hypopituitarism
|
J:324059
|
Mirc33tm1Bdes/Mirc33tm1Bdes
(Not Specified)
|
abnormal thymus involution
|
J:180783
|
Mirc36tm1.1Jcav/Mirc36+
(B6.129-Mirc36tm1.1Jcav)
|
abnormal insulin secretion
|
J:216177
|
Mnx1tm1Jhk/Mnx1tm1Jhk
(involves: 129P2/OlaHsd)
|
abnormal pancreatic beta cell physiology
|
J:57314
|
Mpc2em2Finc/Mpc2em2Finc
(involves: C57BL/6)
|
decreased insulin secretion
|
J:211781
|
Mpgtm1Rhe/Mpgtm1Rhe
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal pancreatic beta cell physiology
|
J:70603
|
Mt1tm1Bri/Mt1tm1Bri Mt2tm1Bri/Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J)
|
increased thymocyte apoptosis
|
J:57169
|
Myd88tm1Aki/Myd88tm1Aki
(involves: 129P2/OlaHsd)
|
abnormal pancreatic beta cell physiology
|
J:148283
|
Myriptm1Tiz/Myriptm1Tiz
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased insulin secretion
|
J:258210
|
Myt1tm1.1Ggu/Myt1tm1.1Ggu
(involves: 129 * C57BL/6 * CBA * CD-1 * SJL)
|
abnormal PP cell physiology
|
J:127471
|
Myt1tm1Ggu/Myt1tm1.1Ggu Tg(Pdx1-cre)89.1Dam/?
(involves: 129 * C57BL/6 * CBA * CD-1 * SJL)
|
abnormal pancreatic alpha cell physiology
|
J:127471
|
abnormal pancreatic somatostatin secretion
|
J:127471
|
abnormal PP cell physiology
|
J:127471
|
decreased insulin secretion
|
J:127471
|
Nabp2tm1.1Kkha/Nabp2tm1.1Kkha Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
increased thymocyte apoptosis
|
J:195140
|
NamptGt(RRT307)Byg/Nampt+
(B6.129P2-NamptGt(RRT307)Byg)
|
decreased insulin secretion
|
J:130534
|
Ncor1tm1.1Anh/Ncor1tm1.1Anh
(involves: 129S4/SvJae * C57BL/6J)
|
decreased activity of thyroid gland
|
J:213990
|
Neurog3tm1(Neurog3,cre/ERT)Ggu/Neurog3tm1(Neurog3,cre/ERT)Ggu Tg(Pdx1-cre/Esr1*)1Mga/0
(involves: 129S6/SvEvTac)
|
abnormal pancreatic beta cell physiology
|
J:150074
|
Nf1tm1Par/Nf1tm1Par Tg(Fabp7-cre,-lacZ)3Gtm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal pituitary gland physiology
|
J:138868
|
Nfatc2tm1Srf/Nfatc2tm1Srf
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal thymus involution
|
J:110686
|
Nfkb2Lym1/Nfkb2Lym1
(involves: BALB/c)
|
abnormal thymus physiology
|
J:154812
|
Nfkbidtm1Clay/Nfkbidtm1Clay
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal thymocyte activation
|
J:132071
|
Nhej1tm1.1Ics/Nhej1tm1.1Ics
(involves: 129 * C57BL/6)
|
increased thymocyte apoptosis
|
J:194422
|
Nhej1tm1.1Ics/Nhej1tm1.1Ics Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
decreased thymocyte apoptosis
|
J:194422
|
Nkx2-2tm1Jlr/Nkx2-2tm1Jlr
(involves: 129X1/SvJ)
|
decreased glucagon secretion
|
J:48576
|
decreased insulin secretion
|
J:48576
|
Nkx6-1tm1Jlr/Nkx6-1tm1Jlr
(involves: 129 * C57BL/6J)
|
decreased insulin secretion
|
J:65594
|
Nnattm1.1Geno/Nnat+ Ins1tm1.1(cre)Thor/Ins1+
(involves: 129S2/SvPas * C57BL/6J)
|
decreased insulin secretion
|
J:265677
|
Nnattm1.2Geno/Nnat+
(either: 129S2(Cg)-Nnattm1.2Geno or B6.129S2(Cg)-Nnattm1.2Geno)
|
decreased insulin secretion
|
J:265677
|
NntC57BL/6J/NntC57BL/6J
(C57BL/6J)
|
decreased insulin secretion
|
J:109356
|
NntG745D/NntG745D
(involves: BALB/c * C3H/HeH)
|
decreased insulin secretion
|
J:108421
|
NntN68K/NntN68K
(involves: BALB/c * C3H/HeH)
|
decreased insulin secretion
|
J:108421
|
Noc2ltm1.1Arte/Noc2ltm1.1Arte Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal thymus involution
|
J:216490
|
increased thymocyte apoptosis
|
J:216490
|
Nogtm1Amc/Nogtm1Amc
(either: (involves: 129S1/Sv * CD-1) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal pituitary gland physiology
|
J:121318
|
Npffr1tm1Lex/Npffr1tm1Lex
(involves: 129 * C57BL/6)
|
abnormal pituitary secretion
|
J:214329
|
Nr2f2tm1Vco/Nr2f2+ Tg(Ins2-cre)25Mgn/0
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA)
|
decreased insulin secretion
|
J:98195
|
increased insulin secretion
|
J:98195
|
Nr3c1tm1.1Jda/Nr3c1+ Tg(Lck-cre)548Jxm/0
(B6.Cg-Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm)
|
decreased thymocyte apoptosis
|
J:189951
|
Nr3c1tm1.1Jda/Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm/0
(B6.Cg-Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm)
|
decreased thymocyte apoptosis
|
J:189951
|
Nr3c1tm1Ljm/Nr3c1tm1Ljm
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal thymocyte apoptosis
|
J:82174
|
Nsmce2tm2.1Ofc/Nsmce2tm2.1Ofc Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * C57BL/6 * SJL)
|
abnormal thymus physiology
|
J:227197
|
Opa1tm1.1Hise/Opa1tm1.2Hise Tg(Ins2-cre)25Mgn/0
(involves: 129S/SvEv * C57BL/6 * DBA * SJL)
|
abnormal pancreatic beta cell physiology
|
J:183074
|
decreased insulin secretion
|
J:183074
|
decreased pancreatic beta cell proliferation
|
J:183074
|
Oprm1tm1Jep/Oprm1tm1Jep
(B6.129S-Oprm1tm1Jep)
|
increased insulin secretion
|
J:147786
|
Or12d17em1Cya/Or12d17em1Cya
(C57BL/6N-Or12d17em1Cya)
|
increased insulin secretion
|
J:321591
|
Orai1tm1Rao/Orai1tm1Rao
(involves: C57BL/6NTac * ICR)
|
abnormal thymocyte activation
|
J:139730
|
Otx1tm1Asim/Otx1tm1Asim
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal pituitary secretion
|
J:47322
|
P2ry14tm1.1Shbg/P2ry14tm1.1Shbg
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased insulin secretion
|
J:223427
|
Parltm1.1Bdes/Parltm1.1Bdes
(involves: 129P2/OlaHsd)
|
abnormal thymus apoptosis
|
J:269785
|
Parltm1Bdes/Parltm1Bdes Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal thymus apoptosis
|
J:269785
|
Pasktm1Weng/Pasktm1Weng
(B6.129S6-Pasktm1Weng)
|
decreased insulin secretion
|
J:125307
|
Pax8tm1Rdl/Pax8tm1.1(cre)Mbu
(B6.129(Cg)-Pax8tm1Rdl Pax8tm1.1(cre)Mbu)
|
decreased activity of thyroid gland
|
J:220108
|
Paxxem1Spj/Paxxem1Spj Nhej1tm1Fwa/Nhej1tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
abnormal thymus involution
|
J:236776
|
Pbx1tm1Mlc/Pbx1+
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased insulin secretion
|
J:75811
|
Pcsk1em2Irli/Pcsk1em2Irli
(C57BL/6J-Pcsk1em2Irli)
|
abnormal pituitary gland physiology
|
J:324309
|
Pcsk2tm1Dfs/Pcsk2tm1Dfs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic somatostatin secretion
|
J:41505
|
decreased glucagon secretion
|
J:41505
|
decreased insulin secretion
|
J:41505
|
increased pancreatic alpha cell proliferation
|
J:85590
|
Pcsk2tm1Dfs/Pcsk2tm1Dfs
(B6;129-Pcsk2tm1Dfs/J)
|
decreased glucagon secretion
|
J:236905
|
Pcxtm1c(EUCOMM)Wtsi/Pcxtm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: C57BL/6 * C57BL/6N * DBA * SJL)
|
abnormal insulin secretion
|
J:332296
|
Pde3btm1Yhc/Pde3btm1Yhc
(129X1/SvJ-Pde3btm1Yhc)
|
increased insulin secretion
|
J:117353
|
Pdpk1tm1Jcbr/Pdpk1tm1Jcbr Tg(Pomc1-cre)16Lowl/0
(involves: C57BL/6 * FVB/N)
|
decreased insulin secretion
|
J:134336
|
Pdpk1tm1Maka/Pdpk1tm1Maka Tg(CAG-cat,-lacZ)11Miya/0 Tg(Pomc1-cre)16Lowl/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N)
|
increased corticotroph apoptosis
|
J:162892
|
increased melanotroph apoptosis
|
J:162892
|
increased pituitary gland apoptosis
|
J:162892
|
Pdx1tm1.1Stof/Pdx1+
(involves: 129/Sv * C57BL/6)
|
abnormal pancreatic endocrine progenitor cell physiology
|
J:152582
|
Pdx1tm1Cvw/Pdx1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic beta cell physiology
|
J:165268
|
decreased insulin secretion
|
J:165268
|
increased pancreatic beta cell apoptosis
|
J:165268
|
Pdx1tm1Cvw/Pdx1+ Pbx1tm1Mlc/Pbx1+
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased insulin secretion
|
J:75811
|
Pdx1tm1Cvw/Pdx1+ SpopGt(BGB118)Byg/Spop+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic beta cell physiology
|
J:165268
|
decreased insulin secretion
|
J:165268
|
Pdx1tm1Cvw/Pdx1tm4Cvw Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss * C57BL/6 * DBA)
|
decreased pancreatic beta cell proliferation
|
J:130389
|
increased pancreatic alpha cell proliferation
|
J:130389
|
Pdx1tm1Heed/Pdx1tm1Heed Tg(Ins2-cre)1Heed/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal pancreatic beta cell physiology
|
J:48516
|
Pdx1tm1Macd/Pdx1tm1Macd Tg(tetO-Ipf1,EGFP)956.6Macd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased insulin secretion
|
J:101742
|
increased glucagon secretion
|
J:101742
|
Pdx1tm1Ted/Pdx1+
(involves: 129P2/OlaHsd)
|
abnormal pancreatic beta cell apoptosis
|
J:82969
|
decreased insulin secretion
|
J:82969
|
Pdx1tm2Cvw/Pdx1+
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
abnormal pancreatic beta cell physiology
|
J:75664
|
decreased amylin secretion
|
J:75664
|
decreased insulin secretion
|
J:75664
|
increased glucagon secretion
|
J:75664
|
Pdx1tm2Cvw/Pdx1+
(involves: 129/Sv * Black Swiss)
|
decreased insulin secretion
|
J:97234
|
Pdx1tm2Cvw/Pdx1+ Slc2a4tm1Mch/Slc2a4+
(involves: 129/Sv * Black Swiss * C57BL/6 * SJL)
|
decreased insulin secretion
|
J:97234
|
Pdzd2Gt(S3-7A1)Sor/Pdzd2Gt(S3-7A1)Sor
(involves: 129S/SvEv * 129S4/SvJaeSor)
|
increased insulin secretion
|
J:307008
|
Pdzd2Gt(S7-9G1)Sor/Pdzd2Gt(S7-9G1)Sor
(involves: 129S/SvEv * 129S4/SvJaeSor)
|
increased insulin secretion
|
J:307008
|
Perptm1Att/Perptm1Att
(involves: 129S4/SvJae)
|
decreased thymocyte apoptosis
|
J:86549
|
PfkmGT(OST56064)Lex/PfkmGT(OST56064)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased insulin secretion
|
J:125530
|
Pgrtm1Bwo/Pgrtm1Bwo
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased insulin secretion
|
J:125584
|
increased pancreatic beta cell proliferation
|
J:125584
|
PhexMhdabap024/Y
(C3HeB/FeJ-PhexMhdabap024)
|
increased activity of parathyroid
|
J:264682
|
PhexMhdabap024/Phex+
(C3HeB/FeJ-PhexMhdabap024)
|
increased activity of parathyroid
|
J:264682
|
Phpt1tm1.1Eys/Phpt1tm1.1Eys
(involves: C57BL/6J * FVB/N)
|
decreased insulin secretion
|
J:262099
|
Pik3cbtm1.1Ehi/Pik3cbtm1.1Ehi
(B6.129P2-Pik3cbtm1.1Ehi)
|
increased insulin secretion
|
J:152332
|
Pik3r1tm1.1Geno/Pik3r1+
(involves: C57BL/6 * C57BL/6J)
|
decreased insulin secretion
|
J:234657
|
Pkd1tm1Shh/Pkd1tm1.1Pcha
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
increased activity of parathyroid
|
J:193544
|
Pla2g10tm1Itl/Pla2g10tm1Itl
(involves: C57BL/6NTac)
|
hypersecretion of corticosterone
|
J:164545
|
Pnptm1Cmr/Pnptm1Cmr
(involves: 129)
|
increased thymocyte apoptosis
|
J:62870
|
Pole3em3Tbo/Pole3em3Tbo
(FVB-Pole3em3Tbo)
|
abnormal thymus apoptosis
|
J:298827
|
increased thymocyte apoptosis
|
J:298827
|
Pole3em4Tbo/Pole3em4Tbo
(FVB-Pole3em4Tbo)
|
abnormal thymus apoptosis
|
J:298827
|
increased thymocyte apoptosis
|
J:298827
|
Polgtm1Prol/Polgtm1Prol
(involves: 129S7/SvEvBrd * C57BL/6J * ICR)
|
abnormal thymus involution
|
J:99764
|
Pou1f1dw/Pou1f1dw
(DW/J Pou1f1dw)
|
increased pituitary gland apoptosis
|
J:108961
|
Ppm1dtm1Lad/Ppm1dtm1Lad
(involves: 129S7/SvEvBrd)
|
decreased pancreatic beta cell proliferation
|
J:151980
|
Prkaa2tm1.1Vio/Prkaa2tm1.1Vio
(involves: 129S2/SvPas * C57BL/6)
|
decreased insulin secretion
|
J:81120
|
Prkacatm3Gsm/Prkacatm3Gsm Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129X1/SvJ * C57BL/6J)
|
decreased insulin secretion
|
J:103418
|
Prkag2tm1.1Geno/Prkag2tm1.1Geno
(B6J.129S(Cg)-Prkag2tm1.1Geno)
|
abnormal pancreatic beta cell physiology
|
J:235379
|
Prkar1atm1.2Lsk/Prkar1atm1.2Lsk Ptentm1.1Mwst/Ptentm1.1Mwst Tg(TPO-cre)1Shk/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/NCr)
|
increased activity of thyroid gland
|
J:225245
|
Prkar1atm1.2Lsk/Prkar1atm1.2Lsk Tg(TPO-cre)1Shk/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/NCr)
|
increased activity of thyroid gland
|
J:241066
|
Prkar1atm1Lsk/Prkar1atm1Lsk Tg(Akr1b7-cre)1Anm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal adrenal gland physiology
|
J:161521
|
increased adrenal gland apoptosis
|
J:161521
|
Prkcdtm1Kin/Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased insulin secretion
|
J:120293
|
Prkdctm1Gcl/Prkdctm1Gcl
(involves: 129S1/Sv)
|
decreased thymocyte apoptosis
|
J:126920
|
Prl3c1tm1(KOMP)Vlcg/Prl3c1tm1(KOMP)Vlcg
(involves: C57BL/6NTac * CD-1)
|
abnormal pituitary gland physiology
|
J:256588
|
Prltm1Hmn/Prltm1Hmn
(involves: 129S2/SvPas)
|
abnormal pituitary secretion
|
J:83246
|
Prlrtm1Cnp/Prlrtm1Cnp
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased insulin secretion
|
J:106829
|
Prop1tm1Sac/Prop1tm1Sac
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6J)
|
hypopituitarism
|
J:94409
|
Ptentm1Hwu/Ptentm1Hwu Tg(CAG-EGFP,-PAX8/PPARG)1Rkoe/0 Tg(TPO-cre)1Shk/0
(involves: 129S4/SvJae * FVB/NCr * FVB/NJ)
|
abnormal thymus physiology
|
J:177181
|
Ptentm1Hwu/Ptentm1Hwu Tg(Ins2-cre)25Mgn/0
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
increased insulin secretion
|
J:170206
|
increased pancreatic beta cell proliferation
|
J:106937
|
Ptpn2tm1Mtr/Ptpn2tm1Mtr
(involves: 129S4/SvJae * BALB/c)
|
abnormal thymus involution
|
J:42595
|
Ptpn11tm1Gsf/Ptpn11tm1Gsf Tg(Camk2a-cre)2Szi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
hypersecretion of corticosterone
|
J:94738
|
Ptpn22tm2Achn/Ptpn22tm2Achn
(B6.Cg-Ptpn22tm2Achn)
|
abnormal thymocyte activation
|
J:147129
|
Ptpn22tm2Achn/Ptpn22tm2Achn Ptprctm1Weis/Ptprctm1Weis
(B6.Cg-Ptprctm1Weis Ptpn22tm2Achn)
|
abnormal thymocyte activation
|
J:147129
|
Ptprcloc/Ptprcloc
(C57BL/6JSfdAnu-Ptprcloc/AnuApb)
|
abnormal thymocyte activation
|
J:104190
|
Ptprctm1Weis/Ptprctm1Weis
(B6.129X1-Ptprctm1Weis)
|
abnormal thymocyte activation
|
J:147129
|
Ptprvtm1Asmi/Ptprvtm1Asmi
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased pancreatic beta cell proliferation
|
J:152695
|
Ptprvtm1Kry/Ptprvtm1Kry Tg(Col1a1-cre)1Kry/0
(involves: FVB)
|
increased insulin secretion
|
J:126780
|
increased pancreatic beta cell proliferation
|
J:126780
|
Pttg1tm1Sme/Pttg1tm1Sme
(involves: 129S4/SvJae * C57BL/6)
|
decreased pancreatic beta cell proliferation
|
J:82724
|
Rab37tm1Hsliu/Rab37tm1Hsliu
(involves: C57BL/6J * C57BL/6N)
|
decreased insulin secretion
|
J:334080
|
Rag2tm1Fwa/Rag2tm1Fwa Tg(TcrHEL3A9)1Mmd/0 Tg(TLK2mHEL)2Ccg/0
(involves: 129S/SvEv * C57BL/6)
|
thyroid gland inflammation
|
J:78309
|
Rai1tm1Jrl/Rai1+
(B6.129S7-Rai1tm1Jrl/J)
|
increased amylin secretion
|
J:164451
|
Rap1gds1tm1Ytk/Rap1gds1tm1Ytk
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
increased thymocyte apoptosis
|
J:62244
|
Rapgef3tm1Skc/Rapgef3tm1Skc
(Not Specified)
|
abnormal pancreatic beta cell physiology
|
J:201171
|
decreased insulin secretion
|
J:201171
|
Rapgef4tm1.1Sse/Rapgef4tm1.1Sse
(Not Specified)
|
abnormal insulin secretion
|
J:128493
|
Rarres2tm1Yktk/Rarres2tm1Yktk
(B6.Cg-Rarres2tm1Yktk)
|
decreased insulin secretion
|
J:206120
|
Rasgrf1tm1Toc/Rasgrf1+
(involves: 129)
|
abnormal pituitary secretion
|
J:47681
|
Rbm4tm1Wtarn/Rbm4tm1Wtarn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal endocrine pancreas physiology
|
J:192831
|
Rcan1tm1Emar/Rcan1tm1Emar
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal adrenal gland secretion
|
J:132495
|
Rictortm1.1Mgn/Rictortm1.1Mgn Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA)
|
abnormal pancreatic beta cell physiology
|
J:170129
|
decreased insulin secretion
|
J:170129
|
decreased pancreatic beta cell proliferation
|
J:170129
|
Rims2tm1Sse/Rims2tm1Sse
(B6.Cg-Rims2tm1Sse)
|
abnormal pancreatic beta cell physiology
|
J:163080
|
decreased insulin secretion
|
J:163080
|
Ripk1tm1.1Vmd/Ripk1tm1.1Vmd
(involves: C57BL/6N)
|
increased thymocyte apoptosis
|
J:209137
|
Ripply3tm1Sjt/Ripply3tm1Sjt
(involves: 129S1/Sv * C57BL/6)
|
increased pancreatic beta cell proliferation
|
J:214095
|
Rnf8Gt(AS0574)Wtsi/Rnf8Gt(AS0574)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
increased thymocyte apoptosis
|
J:161240
|
Rnf8Gt(RRR260)Byg/Rnf8Gt(RRR260)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased thymocyte apoptosis
|
J:161240
|
Rnf146tm1.1Rtpl/Rnf146tm1.1Rtpl Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: C57BL/6J * CD-1)
|
decreased insulin secretion
|
J:244583
|
Rnf213tm1.1Akoi/Rnf213tm1.1Akoi
(involves: C57BL/6N)
|
decreased insulin secretion
|
J:200802
|
Rorctm1Litt/Rorctm1Litt
(involves: 129P2/OlaHsd)
|
increased thymocyte apoptosis
|
J:248565
|
Rorctm2Litt/Rorctm2Litt
(involves: 129P2/OlaHsd)
|
increased thymocyte apoptosis
|
J:87395
|
Rph3altm1Sse/Rph3altm1Sse
(B6.129-Rph3altm1Sse)
|
decreased insulin secretion
|
J:90669
|
Rpl13atm1.1Jesc/Rpl13atm1.1Jesc
(FVB.129S5(Cg)-Rpl13atm1.1Jesc)
|
increased insulin secretion
|
J:237822
|
Rps6tm1Om/Rps6tm1Om
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
decreased insulin secretion
|
J:100952
|
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased insulin secretion
|
J:66406
|
Rps6kb1tm1Gtho/Rps6kb1tm1Gtho
(B6.129P2-Rps6kb1tm1Gtho)
|
abnormal pancreatic beta cell physiology
|
J:144599
|
Rps27lGt(IST11658B7)Tigm/Rps27lGt(IST11658B7)Tigm
(C57BL/6-Rps27lGt(IST11658B7)Tigm)
|
increased thymocyte apoptosis
|
J:223276
|
Rr38tm1.2Aafo/Rr38tm1.2Aafo
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6)
|
abnormal thymus physiology
|
J:227747
|
Rr266em1Hino/Rr266em1Hino Rr268em1Hino/Rr268em1Hino
(C57BL/6J-Rr266em1Hino Rr268em1Hino)
|
decreased insulin secretion
|
J:312429
|
Rr327em1Mgn/Rr327em1Mgn
(C57BL/6J-Rr327em1Mgn)
|
increased insulin secretion
|
J:340414
|
Rr344em1Jfer/Rr344em1Jfer
(B6.Cg-Rr344em1Jfer)
|
abnormal pancreatic somatostatin secretion
|
J:328047
|
decreased glucagon secretion
|
J:328047
|
decreased insulin secretion
|
J:328047
|
Rr395em1Bhao/Rr395em1Bhao
(Not Specified)
|
increased thymocyte apoptosis
|
J:333961
|
Runx1tm1Yg/Runx1tm1Yg
(either: (involves: 129/Sv * 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))
|
increased thymocyte apoptosis
|
J:125830
|
Runx2tm1Kish/Runx2+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased activity of thyroid gland
|
J:162258
|
Samd4m1Btlr/Samd4m1Btlr
(C57BL/6J-Samd4m1Btlr)
|
decreased insulin secretion
|
J:208616
|
Saraftm1c(KOMP)Wtsi/Saraftm1c(KOMP)Wtsi Tg(Pgk1-cre)1Lni/0
(involves: 129S4/SvJaeSor * BALB/c * C57BL/6J * C57BL/6N)
|
decreased activity of thyroid gland
|
J:337869
|
Scarb1tm1Kri/Scarb1+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal adrenal gland physiology
|
J:44187
|
Scarb1tm1Kri/Scarb1tm1Kri
(involves: 129S2/SvPas * C57BL/6)
|
abnormal adrenal gland physiology
|
J:44187
|
Scg3Gt(VICTR20)13Lex/Scg3Gt(VICTR20)13Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal pituitary gland physiology
|
J:256077
|
Sdhbtm1c(EUCOMM)Hmgu/Sdhbtm1c(EUCOMM)Hmgu Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+ Tg(Ins2-cre)23Herr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N * CBA/J)
|
abnormal pancreatic beta cell physiology
|
J:326592
|
Sdhbtm1c(EUCOMM)Hmgu/Sdhbtm1c(EUCOMM)Hmgu Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
abnormal endocrine pancreas physiology
|
J:326592
|
abnormal pancreatic beta cell physiology
|
J:326592
|
decreased insulin secretion
|
J:326592
|
Sec61a1m1Gek/Sec61a1m1Gek
(C57BL/6J-Sec61a1m1Gek)
|
abnormal pancreatic beta cell physiology
|
J:164159
|
increased pancreatic beta cell apoptosis
|
J:164159
|
Selenottm1.1Ics/Selenottm1.1Ics Tg(Ins2-cre)25Mgn/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * DBA)
|
decreased insulin secretion
|
J:203279
|
Senp1tm1.1Eyeh/Senp1tm1.1Eyeh
(Not Specified)
|
abnormal pancreatic beta cell physiology
|
J:226392
|
decreased insulin secretion
|
J:226392
|
Senp1tm1.1Eyeh/Senp1tm1.1Eyeh Tg(Pdx1-cre)6Tuv/0
(involves: C57BL/6)
|
abnormal pancreatic beta cell physiology
|
J:226392
|
decreased insulin secretion
|
J:226392
|
Senp1tm1.1Eyeh/Senp1tm1.1Eyeh Tg(Pdx1-cre/Esr1*)#Dam/0
(involves: C57BL/6)
|
decreased insulin secretion
|
J:226392
|
Senp1tm1Wami/Senp1tm1Wami Tg(Adipoq-cre)1Evdr/0
(B6.Cg-Senp1tm1Wami Tg(Adipoq-cre)1Evdr)
|
decreased insulin secretion
|
J:228009
|
increased pancreatic beta cell apoptosis
|
J:228009
|
Senp1tm1Wami/Senp1tm1Wami Tg(Fabp4-cre)#Abel/0
(B6.Cg-Senp1tm1Wami Tg(Fabp4-cre)#Abel)
|
decreased insulin secretion
|
J:228009
|
Senp1tm1Wami/Senp1tm1Wami Tg(Pdgfra-cre)1Clc/0
(B6.Cg-Senp1tm1Wami Tg(Pdgfra-cre)1Clc)
|
abnormal pancreatic beta cell physiology
|
J:228009
|
Sertad1tm1Srn/Sertad1tm1Srn
(B6.129-Sertad1tm1Srn)
|
decreased insulin secretion
|
J:157231
|
Sgms1tm1Kenw/Sgms1tm1Kenw
(involves: 129S2/SvPas * C57BL/6)
|
decreased insulin secretion
|
J:168726
|
Sgpp2tm1Rlp/Sgpp2tm1Rlp
(B6.129S6-Sgpp2tm1Rlp)
|
abnormal pancreatic beta cell physiology
|
J:235035
|
decreased insulin secretion
|
J:235035
|
decreased pancreatic beta cell proliferation
|
J:235035
|
Sh2b1tm2.1Lr/Sh2b1tm2.1Lr Tg(Pdx1-cre)89.1Dam/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
abnormal pancreatic beta cell physiology
|
J:209019
|
decreased insulin secretion
|
J:209019
|
increased pancreatic beta cell proliferation
|
J:209019
|
Shhtm2Amc/Shhtm2.1Amc Tg(Nr5a1-cre)2Klp/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal adrenal gland physiology
|
J:168522
|
Sidt2tm1.1Hzha/Sidt2tm1.1Hzha
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal insulin secretion
|
J:204228
|
Sirt1tm1Mcby/Sirt1tm1Mcby
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased insulin secretion
|
J:133127
|
Sirt1tm3Fwa/Sirt1tm3Fwa Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal pituitary gland physiology
|
J:155802
|
Slc2a4tm1Mch/Slc2a4+
(involves: 129/Sv * C57BL/6 * SJL)
|
increased insulin secretion
|
J:97234
|
Slc6a3tm1Mca/Slc6a3tm1Mca
(involves: 129P2/OlaHsd)
|
abnormal pituitary gland physiology
|
J:41856
|
abnormal pituitary secretion
|
J:41856
|
hypopituitarism
|
J:41856
|
Slc8a1tm1Herc/Slc8a1+
(involves: 129 * CD-1)
|
increased insulin secretion
|
J:186743
|
increased pancreatic beta cell proliferation
|
J:186743
|
Slc9b2Gt(D174F03)Wrst/Slc9b2Gt(D174F03)Wrst
(involves: 129S2/SvPas * C57BL/6)
|
decreased insulin secretion
|
J:197386
|
Slc9b2tm1.1Dgfu/Slc9b2tm1.1Dgfu
(involves: 129 * C57BL/6)
|
decreased insulin secretion
|
J:197386
|
Slc9b2tm1.1Dgfu/Slc9b2tm1.1Dgfu
(B6.129-Slc9b2tm1.1Dgfu)
|
decreased insulin secretion
|
J:197386
|
Slc17a9tm1Nomu/Slc17a9tm1Nomu
(involves: 129 * C57BL/6J)
|
abnormal adrenal gland physiology
|
J:256580
|
abnormal neuroendocrine gland physiology
|
J:256580
|
Slc23a2tm1Nbm/Slc23a2tm1Nbm
(129S6/SvEvTac-Slc23a2tm1Nbm)
|
abnormal adrenal gland secretion
|
J:85988
|
Slc26a7tm1Sole/Slc26a7tm1Sole
(involves: 129)
|
abnormal thyroid gland physiology
|
J:325346
|
decreased activity of thyroid gland
|
J:325346
|
Slc30a8tm1.1Geno/Slc30a8tm1.1Geno
(involves: 129/Sv * C57BL/6JRj)
|
abnormal pancreatic beta cell physiology
|
J:153253
|
decreased insulin secretion
|
J:153253
|
Slc30a8tm1.1Htwt/Slc30a8tm1.1Htwt Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * CBA/JNCrlj * DBA)
|
increased insulin secretion
|
J:204003
|
Slc30a8tm1Lex/Slc30a8tm1Lex
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased insulin secretion
|
J:152629
|
Slc30a10tm1.1Sommu/Slc30a10tm1.1Sommu
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA)
|
decreased activity of thyroid gland
|
J:243657
|
Slc39a8tm1.1Brvo/Slc39a8tm1.1Brvo
(involves: C57BL/6)
|
increased insulin secretion
|
J:341571
|
Slc39a10tm1.1Tfk/Slc39a10tm1.1Tfk Tg(Foxn1-cre)8Ghr/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
increased thymocyte apoptosis
|
J:254216
|
Smad3tm1Cxd/Smad3tm1Cxd
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss))
|
abnormal thymus involution
|
J:53510
|
Smad4tm2.1Cxd/Smad4tm2.1Cxd Tg(Foxn1-cre)8Ghr/0
(B6.Cg-Smad4tm2.1Cxd Tg(Foxn1-cre)8Ghr)
|
abnormal thymus physiology
|
J:138837
|
Snai2tm2Grid/Snai2tm2Grid Snai3tm1.2Jhws/Snai3tm1.2Jhws
(involves: 129/Sv * 129S1/Sv * C57BL/6)
|
abnormal thymus involution
|
J:204710
|
Snap25Bdr/Snap25+
(involves: BALB/cAnNCrl)
|
abnormal pancreatic beta cell physiology
|
J:119733
|
decreased glucagon secretion
|
J:119733
|
decreased insulin secretion
|
J:119733
|
Snap25tm1.1Bark/Snap25tm1.1Bark
(Not Specified)
|
abnormal insulin secretion
|
J:226064
|
Snapintm1Zhs/Snapintm1Zhs
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal adrenal gland secretion
|
J:102725
|
Sox4Igt4/Sox4+
(involves: C3H/HeH * C57BL/6)
|
decreased insulin secretion
|
J:141688
|
Sox4M91Ark/Sox4+
(involves: C3H/HeH)
|
decreased insulin secretion
|
J:141688
|
Sox9tm1Gsr/Sox9+ Tg(Pdx1-cre)6Cvw/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA * FVB/N)
|
decreased glucagon secretion
|
J:141017
|
decreased insulin secretion
|
J:141017
|
Sphkaptm1.1Nina/Sphkaptm1.1Nina
(Not Specified)
|
decreased insulin secretion
|
J:272327
|
increased insulin secretion
|
J:272327
|
SpopGt(BGB118)Byg/Spop+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pancreatic beta cell physiology
|
J:165268
|
Srrttm1.1Thsn/Srrttm1.2Thsn Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal thymus physiology
|
J:152729
|
Srxn1tm1Sgrh/Srxn1tm1Sgrh Tg(Cyp11a1-cre)16Mchu/?
(involves: C57BL/6J)
|
abnormal adrenal gland secretion
|
J:222986
|
Sstr5tm1Fcb/Sstr5tm1Fcb
(involves: 129)
|
increased insulin secretion
|
J:179577
|
Sstr5tm1Fcb/Sstr5tm2Fcb Tg(Ins2-cre)1Heed/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
decreased insulin secretion
|
J:99786
|
increased insulin secretion
|
J:99786
|
Sstr5tm1Hawi/Sstr5tm1Hawi
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased insulin secretion
|
J:101259
|
St14tm1Bug/St14tm1Bug
(involves: 129P2/OlaHsd * Black Swiss)
|
increased thymocyte apoptosis
|
J:87125
|
Stat3tm1Dnl/Stat3tm1Dlv
(involves: C57BL/6)
|
increased thymocyte apoptosis
|
J:87599
|
Stat4tm1Gru/Stat4tm1Gru
(NOD.129S2-Stat4tm1Gru)
|
abnormal insulin secretion
|
J:90600
|
Stat5atm2Mam/Stat5atm2Mam Stat5btm1Mam/Stat5btm1Mam Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
decreased insulin secretion
|
J:127051
|
Stat5atm2Mam/Stat5atm2Mam Tg(Ins2-cre)23Herr/0
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J)
|
decreased pancreatic beta cell proliferation
|
J:284574
|
Stat5btm1Mam/Stat5btm1Mam Tg(Ins2-cre)25Mgn/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA)
|
decreased insulin secretion
|
J:127051
|
Stk38tm1Hem/Stk38tm1Hem
(involves: 129P2/Ola * C57BL/6)
|
decreased thymocyte apoptosis
|
J:185408
|
Stub1tm1Cpat/Stub1tm1Cpat
(involves: 129S/SvEv * C57BL/6)
|
increased thymocyte apoptosis
|
J:86213
|
Stxbp3tm1Jpes/Stxbp3+
(B6.129-Stxbp3tm1Jpes)
|
decreased insulin secretion
|
J:96731
|
Syt1tm1Sud/Syt1tm1Sud
(involves: 129S4/SvJae)
|
abnormal adrenal gland physiology
|
J:171203
|
Sytl1tm1Tiz/Sytl1tm1Tiz
(C3.Cg-Sytl1tm1Tiz)
|
decreased insulin secretion
|
J:200233
|
Sytl1tm1Tiz/Sytl1tm1Tiz Sytl4tm1Tiz/Sytl4tm1Tiz
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6NTac)
|
decreased insulin secretion
|
J:200233
|
Sytl4tm1Tiz/Y
(involves: 129P2/OlaHsd)
|
hypersecretion of adrenocorticotropin
|
J:145238
|
Sytl4tm1Tiz/Sytl4tm1Tiz
(involves: 129P2/OlaHsd * C3H/He)
|
increased insulin secretion
|
J:102610
|
Taf7tm1.1Dss/Taf7tm1.2Dss Tg(Lck-cre)1Cwi/0
(involves: C57BL/6)
|
abnormal thymus physiology
|
J:185745
|
tb/tb
(Not Specified)
|
abnormal thymus involution
|
J:12166
|
Tcf7l2tm1Geno/Tcf7l2tm1Geno Tg(Pdx1-cre)89.1Dam/0
(involves: C57BL/6 * CBA)
|
decreased insulin secretion
|
J:189204
|
Tcirg1oc/Tcirg1oc
(B6C3Fe a/a-Tcirg1oc/J)
|
decreased insulin secretion
|
J:116082
|
Tfamtm1Lrsn/Tfamtm1Lrsn Tg(Ins2-cre)25Mgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
decreased insulin secretion
|
J:65522
|
Tfap2atm1Will/Tfap2atm1Will
(involves: Black Swiss)
|
abnormal adrenal gland secretion
|
J:81338
|
Tfb2mtm1a(KOMP)Wtsi/Tfb2m+ Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
decreased insulin secretion
|
J:256448
|
Tfb2mtm1a(KOMP)Wtsi/Tfb2mtm1a(KOMP)Wtsi Tg(Ins2-cre)23Herr/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
decreased insulin secretion
|
J:256448
|
Tg(APCS-RARRES2)9Yktk/0
(involves: C57BL/6)
|
increased insulin secretion
|
J:206120
|
Tg(APOE-FGF23*R176Q)#Ack/0
(involves: C57BL/6J * CBA)
|
increased activity of parathyroid
|
J:93981
|
Tg(AZIP/F)1Vsn/0
(FVB-Tg(AZIP/F)1Vsn/J)
|
increased insulin secretion
|
J:145998
|
increased pancreatic beta cell proliferation
|
J:145998
|
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0 Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6 * C57BL/10)
|
decreased thymocyte apoptosis
|
J:217939
|
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0 Tg(LCKprBCL2)36Sjk/0
(involves: C57BL/6 * C57BL/10)
|
decreased thymocyte apoptosis
|
J:217939
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6)
|
decreased thymocyte apoptosis
|
J:217939
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6 * CBA/J)
|
decreased thymocyte apoptosis
|
J:217939
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0 Tg(Nr4a1-EGFP/cre)820Khog/0
(involves: C57BL/6 * C57BL/6J)
|
decreased thymocyte apoptosis
|
J:217939
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
decreased thymocyte apoptosis
|
J:217939
|
Tg(Cd4-Dtx1)1Mzl/?
(involves: C57BL/6)
|
abnormal thymocyte activation
|
J:151605
|
Tg(Cd4-TGFBR2)16Flv/?
(involves: C3H * C57BL/6 * C57BL/10 * C57BR/cd)
|
abnormal thymus involution
|
J:97554
|
Tg(Col1a1-Atf4)1Kry/0
(involves: FVB)
|
decreased insulin secretion
|
J:152695
|
decreased pancreatic beta cell proliferation
|
J:152695
|
Tg(Col1a1-Ptprv)1Kry/?
(Not Specified)
|
decreased insulin secretion
|
J:126780
|
decreased pancreatic beta cell proliferation
|
J:126780
|
Tg(Crh)227.1Pbl/0
(involves: C57BL/6 * SJL)
|
hypersecretion of adrenocorticotropin
|
J:92996
|
Tg(Cryaa-TAg,Ins2-CALM1)26Ove/0
(FVB(Cg)-Tg(Cryaa-Tag,Ins2-CALM1)26Ove/PneJ)
|
decreased insulin secretion
|
J:97926
|
Tg(DO11.10)10Dlo/?
(involves: BALB/c * C3H * C57BL/6)
|
abnormal thymus physiology
|
J:70572
|
Tg(Fabp4-LEP)F8Ffc/?
(B6.Cg-Tg(Fabp4-LEP)F8Ffc)
|
increased insulin secretion
|
J:84349
|
Tg(Gpbar1)1Auw/0
(involves: C57BL/6J)
|
increased insulin secretion
|
J:152388
|
Tg(Ins1-Cat,Tyr)25Pne/0
(involves: FVB)
|
increased insulin secretion
|
J:59275
|
Tg(Ins1-Kcnj11*)#Nich/?
(B6.Cg-Tg(Ins1-Kcnj11*)#Nich)
|
increased insulin secretion
|
J:94610
|
Tg(Ins2-Akt1*)3Mbb/0
(involves: C57BL/6 * SJL)
|
abnormal insulin secretion
|
J:72216
|
abnormal pancreatic beta cell physiology
|
J:72216
|
Tg(Ins2-Cebpb)2Maka/0
(involves: C57BL/6)
|
decreased insulin secretion
|
J:156725
|
Tg(Ins2-Chrm3*)1Jwe/0
(involves: C57BL/6)
|
increased insulin secretion
|
J:129643
|
Tg(Ins2-cre)25Mgn/0
(involves: C57BL/6 * DBA)
|
decreased insulin secretion
|
J:127051
|
Tg(Ins2-cre)25Mgn/0
(either: (B6.Cg-Tg(Ins2-cre)25Mgn/J) or (involves: 129 * C57BL/6 * DBA/2))
|
abnormal insulin secretion
|
J:108244
|
Tg(Ins2-GLUD1*H454Y)1Csta/0
(involves: C57BL/6 * SJL)
|
abnormal pancreatic beta cell physiology
|
J:113458
|
increased insulin secretion
|
J:113458
|
Tg(Ins2-GLUD1*H454Y)2Csta/0
(involves: C57BL/6 * SJL)
|
abnormal insulin secretion
|
J:113458
|
abnormal pancreatic beta cell physiology
|
J:113458
|
Tg(Ins2-H2-Ead,Ins2-H2-Eb1b)187-7Bri/0
(involves: C57BL/6 * SJL)
|
decreased insulin secretion
|
J:127706
|
Tg(Ins2-Hnf1a)#Cbw/0
(involves: C57BL/6 * CBA/J)
|
decreased insulin secretion
|
J:134757
|
increased glucagon secretion
|
J:134757
|
Tg(Ins2-IAPP)L13Gjsc/0
(FVB/N-Tg(Ins2-IAPP)L13Gjsc)
|
abnormal pancreatic beta cell physiology
|
J:142009
|
decreased insulin secretion
|
J:142009
|
increased amylin secretion
|
J:142009
|
increased pancreatic beta cell apoptosis
|
J:142009
|
Tg(Ins2-IAPP)RHFSoel/Tg(Ins2-IAPP)RHFSoel
(involves: FVB/N)
|
decreased insulin secretion
|
J:130022
|
increased pancreatic beta cell apoptosis
|
J:130022
|
Tg(Ins2-Irs2)13Mfw/0
(involves: C57BL/6)
|
increased insulin secretion
|
J:94000
|
Tg(Ins2-Mir184)4Mnpy/0
(Not Specified)
|
decreased insulin secretion
|
J:210552
|
decreased pancreatic beta cell proliferation
|
J:210552
|
Tg(Ins2-Mir184)96Mnpy/0
(Not Specified)
|
decreased insulin secretion
|
J:210552
|
Tg(Ins2-Mirc13)E4Biat/0
(C57BL/6N-Tg(Ins2-Mirc13)E4Biat)
|
decreased insulin secretion
|
J:314874
|
increased pancreatic beta cell apoptosis
|
J:314874
|
Tg(Ins2-OVA)59Wehi/?
(involves: BALB/c * C57BL/6)
|
abnormal pancreatic beta cell physiology
|
J:99560
|
Tg(Ins2-OVA)307Wehi/?
(involves: BALB/c * C57BL/6)
|
abnormal pancreatic beta cell physiology
|
J:99560
|
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Ago2)30Mnpy/0
(involves: C57BL/6 * CBA)
|
decreased insulin secretion
|
J:210552
|
increased pancreatic beta cell proliferation
|
J:210552
|
Tg(Ins2-rtTA)2Efr/0 Tg(tetO-Mir184)#Mnpy/0
(involves: C57BL/6 * CBA)
|
decreased pancreatic beta cell proliferation
|
J:210552
|
Tg(Ins2-TCF1*P291)2Kya/0
(involves: C57BL/6 * SJL)
|
abnormal pancreatic beta cell physiology
|
J:73760
|
decreased insulin secretion
|
J:73760
|
decreased pancreatic beta cell proliferation
|
J:73760
|
Tg(Ins-Igf2)1Fbos/0
(involves: C57BL/6 * SJL)
|
abnormal pancreatic beta cell physiology
|
J:141527
|
increased insulin secretion
|
J:141527
|
Tg(Lck-CrmA)1Hed/?
(involves: BALB/c * C57BL/6J)
|
decreased thymocyte apoptosis
|
J:100451
|
Tg(Lck-FADD)1Hed/?
(involves: BALB/c * C57BL/6)
|
decreased thymocyte apoptosis
|
J:100451
|
Tg(Lck-Sox13)#Jskg/0
(involves: C57BL/6)
|
increased thymocyte apoptosis
|
J:117301
|
Tg(LckIl4)1315Dbl/0
(involves: C57BL/6J * DBA/2J)
|
abnormal thymocyte activation
|
J:92453
|
Tg(LCKprBCL2)36Sjk/0
(involves: C57BL/6 * CBA/J)
|
decreased thymocyte apoptosis
|
J:217939
|
Tg(LCKprBCL2)36Sjk/0 Tg(Nr4a1-EGFP/cre)820Khog/0
(involves: C57BL/6 * C57BL/6J)
|
decreased thymocyte apoptosis
|
J:217939
|
Tg(LCKprBCL2)36Sjk/0 Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
decreased thymocyte apoptosis
|
J:217939
|
Tg(ML5sHEL)5Ccg/0 Tg(TcrHEL3A9)1Mmd/0 Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6JSfd * C57BL/10 * C57BR/cd)
|
thyroid gland inflammation
|
J:78309
|
Tg(Pdx1-Ffar1)AHeed/0
(Not Specified)
|
abnormal pancreatic beta cell physiology
|
J:129843
|
decreased insulin secretion
|
J:129843
|
Tg(PTH-CCND1)PC2Anar/0
(FVB/N-Tg(PTH-CCND1)PC2Anar)
|
abnormal parathyroid gland physiology
|
J:69423
|
Tg(RCAN1)M9Mapr/?
(involves: C57BL/6 * CBA)
|
abnormal adrenal gland secretion
|
J:132495
|
Tg(RP3-340H11)29Kel/0
(involves: C57BL/6J * CBA/Ca)
|
abnormal pancreatic beta cell physiology
|
J:91709
|
increased insulin secretion
|
J:91709
|
Tg(TCF3/HLF)1Mlc/0
(involves: FVB/N)
|
abnormal thymus involution
|
J:55022
|
Tg(TcrAND)53Hed/?
(involves: A/WySnSg * C57BL/6 * C57BL/10SnSg * SJL)
|
abnormal thymocyte activation
|
J:85777
|
Tg(TcrHEL3A9)1Mmd/0 Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
thyroid gland inflammation
|
J:78309
|
Tg(tetO-BRAF*V600E)26Jaf/0 Tg(TG-rtTA)30Jaf/0
(involves: FVB/N)
|
decreased activity of thyroid gland
|
J:184420
|
Tg(TG-RET/CCDC6)42Cled/0
(involves: FVB/N)
|
abnormal thyroid gland physiology
|
J:55883
|
decreased activity of thyroid gland
|
J:55883,
J:93679
|
Tg(TG-SV40)#Cled/0
(involves: C57BL/6J * DBA/2J)
|
decreased activity of thyroid gland
|
J:209788
|
iodide oxidation defect
|
J:209788
|
Tg(Trp53)1Srn/0
(involves: C57BL/6 * CBA)
|
increased thymocyte apoptosis
|
J:80311
|
Tg(Trp53)1Srn/0 Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
decreased thymocyte apoptosis
|
J:80311
|
Tg(Trp53)bSrn/0
(involves: C57BL/6 * CBA)
|
increased thymocyte apoptosis
|
J:80311
|
Tg(VDR*L233S,luc)T807Pike/0 Vdrtm1Mbd/Vdrtm1Mbd
(involves: 129S4/SvJae * C57BL/6)
|
increased activity of parathyroid
|
J:218709
|
Tgfbitm1Jwu/Tgfbitm1Jwu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal pancreatic beta cell physiology
|
J:213611
|
Tgfbitm1Jwu/Tgfbitm1Jwu
(B6.129-Tgfbitm1Jwu)
|
decreased insulin secretion
|
J:213611
|
increased pancreatic beta cell apoptosis
|
J:213611
|
Thratm1.1Fcas/Thratm1.1Fcas
(B6.Cg-Thratm1.1Fcas)
|
abnormal insulin secretion
|
J:179839
|
increased glucagon secretion
|
J:179839
|
increased insulin secretion
|
J:179839
|
Thratm1Syc/Thra+
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
decreased activity of thyroid gland
|
J:73446
|
Thratm1Ven/Thratm1Ven
(involves: 129P2/OlaHsd * BALB/c)
|
decreased activity of thyroid gland
|
J:45675
|
Thratm2Jas/Thratm2Jas
(involves: 129)
|
decreased activity of thyroid gland
|
J:120899
|
Thratm2Ven/Thra+
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal thyroid gland physiology
|
J:72959
|
decreased activity of thyroid gland
|
J:72959
|
increased activity of thyroid gland
|
J:72959
|
Thratm2Ven/Thratm2Ven
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal thyroid gland physiology
|
J:72959
|
decreased activity of thyroid gland
|
J:72959
|
increased activity of thyroid gland
|
J:72959
|
Thrbtm1.1Syc/Thrb+
(involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss)
|
abnormal pituitary gland physiology
|
J:65885
|
Thrbtm1.1Syc/Thrbtm1.1Syc
(involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss)
|
abnormal pituitary gland physiology
|
J:65885
|
Thrbtm1Df/Thrbtm1Df
(involves: 129S1/Sv * C57BL/6J)
|
increased activity of thyroid gland
|
J:34421
|
Thrbtm1Few/Thrbtm1Few
(involves: 129S4/SvJae)
|
abnormal thyroid gland physiology
|
J:56668
|
Thrbtm1Olc/Thrbtm1Olc
(involves: 129)
|
increased activity of thyroid gland
|
J:120899
|
Thrbtm3Few/Thrbtm3Few
(involves: 129 * C57BL/6)
|
abnormal pituitary gland physiology
|
J:85158
|
increased activity of thyroid gland
|
J:85158
|
Thrbtm4Few/Thrbtm4Few
(involves: 129 * C57BL/6)
|
abnormal pituitary gland physiology
|
J:85158
|
TiparpGt(ROSA)79Sor/TiparpGt(ROSA)79Sor
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6J)
|
abnormal thymus involution
|
J:250417
|
Tk1tm1Vnd/Tk1tm1Vnd
(involves: 129P2/OlaHsd * C57BL/6)
|
thyroid gland inflammation
|
J:101669
|
Tle4tm1.2Dasw/Tle4tm1.2Dasw
(B6.129S6(Cg)-Tle4tm1.2Dasw)
|
increased thymocyte apoptosis
|
J:219243
|
Tlr2tm1Kir/Tlr2tm1Kir
(B6.129-Tlr2tm1Kir)
|
increased insulin secretion
|
J:162168
|
Tlr2tm1Kir/Tlr2tm1Kir
(involves: 129)
|
abnormal adrenal gland secretion
|
J:94463
|
Tlr3tm1Flv/Tlr3tm1Flv
(involves: 129S1/Sv)
|
abnormal pancreatic beta cell physiology
|
J:135353
|
Tmem109tm1Yamt/Tmem109tm1Yamt
(B6.Cg-Tmem109tm1Yamt)
|
decreased thymocyte apoptosis
|
J:157864
|
Tmem117tm1.1Thor/Tmem117tm1.1Thor
(involves: C57BL/6N)
|
increased glucagon secretion
|
J:339175
|
Tpcn2Gt(YHD437)Byg/Tpcn2Gt(YHD437)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pancreatic beta cell physiology
|
J:149472
|
Tph1tm1c(KOMP)Wtsi/Tph1tm1c(KOMP)Wtsi Tg(Ins2-cre)23Herr/0
(involves: 129S4/SvJae * C57BL/6J * CBA/J)
|
decreased pancreatic beta cell proliferation
|
J:284574
|
Tpotee-2J/Tpotee-2J
(B6.Cg-Tpotee-2J H2g7/GrsrJ)
|
abnormal thyroid gland physiology
|
J:202956
|
decreased activity of thyroid gland
|
J:202956
|
Tpotee/Tpotee
(C57BL/6J-Tpotee/GrsrJ)
|
abnormal thyroid gland physiology
|
J:202956
|
decreased activity of thyroid gland
|
J:202956
|
Tpst2grt/Tpst2grt
(involves: DW/JMuaf)
|
decreased activity of thyroid gland
|
J:122398
|
Traf2tm1Mak/Traf2tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6J))
|
increased thymocyte apoptosis
|
J:44360
|
Trhtm1Mmt/Trhtm1Mmt
(involves: C57BL/6 * CBA * ICR)
|
decreased insulin secretion
|
J:43657
|
Trhrtm1Bau/Trhrtm1Bau
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased activity of thyroid gland
|
J:220755
|
Trib3Gt(OST324148)Lex/Trib3Gt(OST324148)Lex
(B6;129S5-Trib3Gt(OST324148)Lex/Ieg)
|
decreased pancreatic beta cell apoptosis
|
J:217758
|
Trp53tm1.1Awbr/Trp53tm1.1Awbr
(involves: C57BL/6)
|
decreased thymocyte apoptosis
|
J:173271
|
Trp53tm1.1Thst/Trp53tm1.1Thst
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
decreased thymocyte apoptosis
|
J:198482
|
Trp53tm1.1Tldo/Trp53tm1.1Tldo
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
increased thymocyte apoptosis
|
J:199308
|
Trp53tm1.1Wgu/Trp53tm1.1Wgu
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased thymocyte apoptosis
|
J:186159
|
Trp53tm1.2Awbr/Trp53tm1.2Awbr
(involves: C57BL/6)
|
decreased thymocyte apoptosis
|
J:173271
|
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd)
|
abnormal thymus physiology
|
J:175018
|
decreased thymocyte apoptosis
|
J:186159
|
Trp53tm1Brd/Trp53tm1Brd Trp73tm2Mak/Trp73tm2Mak
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
decreased thymocyte apoptosis
|
J:157905
|
Trp53tm1Glo/Trp53tm1Glo
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased thymocyte apoptosis
|
J:172038
|
Trp53tm1Holl/Trp53tm7.1Xu
(involves: 129P2/OlaHsd)
|
decreased thymocyte apoptosis
|
J:160414
|
Trp53tm1Thst/Trp53tm1Thst
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased thymocyte apoptosis
|
J:198482
|
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas)
|
decreased thymocyte apoptosis
|
J:158953
|
Trp53tm1Tyj/Trp53+
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
decreased thymocyte apoptosis
|
J:80311
|
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas)
|
decreased thymocyte apoptosis
|
J:158953,
J:195018,
J:126920
|
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
decreased thymocyte apoptosis
|
J:80311
|
Trp53tm1Xu/Trp53tm1Xu
(involves: 129S4/SvJae)
|
abnormal thymocyte apoptosis
|
J:86185
|
Trp53tm2.1Snj/Trp53tm2.1Snj
(involves: 129S4/SvJae * C57BL/6)
|
abnormal thymus physiology
|
J:175018
|
Trp53tm2.1Wgu/Trp53tm2.1Wgu
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased thymocyte apoptosis
|
J:186159
|
Trp53tm3.1Holl/Trp53tm3.1Holl
(Not Specified)
|
increased thymocyte apoptosis
|
J:191183
|
Trp53tm7.1Xu/Trp53+
(Not Specified)
|
abnormal thymus physiology
|
J:160414
|
Trp53tm7.1Xu/Trp53tm7.1Xu
(Not Specified)
|
abnormal thymus physiology
|
J:160414
|
decreased thymocyte apoptosis
|
J:160414
|
Trp73tm2Mak/Trp73tm2Mak
(either: B6.129P2-Trp73tm2Mak or (involves: 129P2/OlaHsd * C57BL/6J))
|
increased thymocyte apoptosis
|
J:157905
|
Tshrhyt-3J/Tshrhyt-3J
(CXB10/HiAJ-Tshrhyt-3J/GrsrJ)
|
decreased activity of thyroid gland
|
J:210510
|
Tshrhyt-3J/Tshrhyt-3J
(CByJ;CXB10-Tshrhyt-3J/GrsrJ)
|
decreased activity of thyroid gland
|
J:210510
|
Tshrhyt/Tshrhyt
(CBy.RF-Tshrhyt/J)
|
decreased activity of thyroid gland
|
J:130062
|
Tshrtm1Rmar/Tshrtm1Rmar
(involves: 129S1/Sv * C57BL/6J)
|
abnormal thyroid gland physiology
|
J:80513
|
decreased activity of thyroid gland
|
J:80513
|
iodide oxidation defect
|
J:80513
|
Twsg1tm1Nosa/Twsg1tm1Nosa
(involves: 129P2/OlaHsd * C57BL/6)
|
increased thymocyte apoptosis
|
J:82738
|
Ucn3tm1Pbl/Ucn3tm1Pbl
(Not Specified)
|
decreased insulin secretion
|
J:119417
|
Unc13atm1Bros/Unc13a+
(involves: 129)
|
decreased insulin secretion
|
J:215257,
J:108689
|
Uoxem1Cli/Uoxem1Cli
(C57BL/6J-Uoxem1Cli)
|
decreased insulin secretion
|
J:271949
|
increased pancreatic beta cell apoptosis
|
J:271949
|
Usp4tm1Xilu/Usp4tm1Xilu
(B6.129-Usp4tm1Xilu)
|
increased thymocyte apoptosis
|
J:173192
|
Vamp4em1Tax/Vamp4em1Tax
(involves: C57BL/6J)
|
abnormal pancreatic beta cell physiology
|
J:352764
|
increased insulin secretion
|
J:352764
|
Vav2tm1Tnr/Vav2tm1Tnr
(involves: 129P2/OlaHsd)
|
abnormal adrenal gland secretion
|
J:124056
|
Vdac2tm1.1Ehyc/Vdac2tm1.1Ehyc Tg(Lck-cre)1Cwi/?
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal thymocyte apoptosis
|
J:220951
|
Vdrtm1.2Sgcg/Vdrtm1.2Sgcg
(involves: 129 * C57BL/6 * CBA * SJL)
|
increased activity of parathyroid
|
J:189471
|
Vdrtm1Rge/Vdrtm1Rge
(involves: 129S1/Sv * 129X1/SvJ)
|
increased activity of parathyroid
|
J:77748
|
Vdrtm2.1Ska/Vdrtm2.1Ska
(involves: C57BL/6 * CBA/JNCrlj * SJL)
|
increased activity of parathyroid
|
J:196471
|
Vps13ctm1.1Geno/Vps13ctm1.1Geno
(involves: C57BL/6)
|
abnormal pancreatic beta cell physiology
|
J:241413
|
abnormal pancreatic beta cell physiology
|
J:241413
|
Wastm1Sbs/Wastm1Sbs
(involves: 129S6/SvEvTac)
|
abnormal thymocyte activation
|
J:125309
|
Wastm1Sbs/Wastm1Sbs Wasltm2Sbs/Wasltm2Sbs Tg(Lck-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal thymocyte activation
|
J:125309
|
Wdr13tm1Kuma/Y
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased pancreatic beta cell proliferation
|
J:225111
|
Wfs1tm1Perm/Wfs1tm1Perm Tg(Ins2-cre)23Herr/0
(involves: 129X1/SvJ * C57BL/6J * CBA/J)
|
abnormal pancreatic beta cell physiology
|
J:104712
|
decreased insulin secretion
|
J:104712
|
Wfs1tm1Yoka/Wfs1tm1Yoka
(involves: 129/Sv * C57BL/6)
|
increased glucagon secretion
|
J:90420
|
Wfs1tm1Yoka/Wfs1tm1Yoka
(B6.Cg-Wfs1tm1Yoka)
|
increased glucagon secretion
|
J:90420
|
Wnt4tm1Amc/Wnt4tm1Amc
(involves: 129/Sv * CD-1)
|
abnormal adrenal gland physiology
|
J:80420
|
Wwoxtm1Ria/Wwoxtm1Ria
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal pituitary gland physiology
|
J:146986
|
Xdhrenf/Xdhrenf
(involves: C3H * C57BL/6J)
|
increased activity of parathyroid
|
J:187066
|
Zap70m1Saka/Zap70m1Saka
(involves: BALB/c)
|
abnormal thymocyte activation
|
J:154166
|
Zap70tm2.1Weis/Zap70tm2.1Weis
(C.129S4-Zap70tm2.1Weis)
|
abnormal thymocyte activation
|
J:154166
|
Zfp131tm1.1Mytk/Zfp131tm1.1Mytk Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
abnormal thymocyte activation
|
J:271921
|